EN   EN 
 
 
 EUROPEAN  
COMMISSION   
Brussels, XXX   
SANTE/7068/2019 ANNEX CIS 
(POOL/G2/2019/7068/7068 -EN 
ANNEX CIS.doc)  
[…](2019) XXX  draft  
ANNEXES 1 to 30  
 
ANNEXES  
to the  
COMMISSION DELEGATED REGULATION (EU) .../...  
on animal health requirements for the entry into the Union, movement and handling 
after entry of certain animals, germinal products and products for animal origin from 
third countries or territories    
EN 1  EN ANNEX I  
LIST OF  DISEASES REQUIRED TO BE NOTIFIED AND REPORTED IN THE 
EXPORTING THIRD COUNTRY OR TERRITORY   
1. TERRESTRIAL ANIMALS  
All the listed diseases referred to in Article 5 of Regulation (EU) 2016/429 , and 
listed in Annex II thereto for the listed  species of terrestrial animals in the Annex to 
Regulation (EU) 2018/1882 . 
2. GERMINAL PRODUCTS  
2.1. From ungulates  
– Foot and mouth disease  
– Infection with Brucella  abortus, B.melitensis  and B.suis  
– Infection with Mycobacterium tuberculosis complex ( M. bovis, M.caprae and 
M. tuberculosis )  
– Infection with bluetongue virus ( serotypes 1 -24) 
– Infection with epizootic haemorragic disease virus  
– Infecti ous bovine rhinotracheitis/infectious pustular vulvovaginitis  
– Bovine viral diarrhoea  
– Bovine genital campylobacteriosis  
– Trichomonosis  
– Enzootic bovine leu Kosis 
– Ovine epididymitis ( Brucella ovis ) 
– Infection with equine arteritis virus  
– Equine infectious anemia  
– Contagious equine metritis  
– Classical swine fever  
– Infection with Aujeszky's disease virus  
– Infection with porcine reproductive and respiratory syndrome virus  
2.2. From poultry and captive birds  
All the listed diseases referred to in Article 5 of Regulation (EU) 2 016/429 and listed 
in Annex II thereto , relevant for the listed species of poultry and captive birds  in the 
Annex to Regulation (EU) 2018/1882 , from which germinal products authorised to 
enter the Union are obtained .  
EN 2  EN 3. PRODUCTS OF ANIMAL OR IGIN FROM UNGULATES , POULTRY AND WILD GAM E BIRDS  
3.1. Fresh meat from ungulates  
– Foot and mouth disease  
– Infection with rinderpest virus  
– Infection with Rift Valley virus  
– Sheep pox and goat pox  
– Peste des petits ruminants  
– Classical swine fever  
– African swine fever  
3.2. Fresh meat from poultry and wild game birds  
– Highly pathogenic avian influenza  
– Infection with Newcastle disease virus  
3.3. Meat products from ungulates  
– Foot and mouth disease  
– Infection with rinderpest virus  
– Classical swine fever  
– African swine fever  
3.4. Meat products from poult ry and wild game birds  
– Highly pathogenic avian influenza  
– Infection with Newcastle disease virus  
3.5. Milk, colostrum, dairy products and colostrum -based products  
– Foot and mouth disease  
– Infection with rinderpest virus  
4. AQUATIC ANIMALS AND PRODUCTS OF ANIMAL OR IGIN FROM AQUATIC ANIMA LS 
– Epizootic haematopoietic necrosis  
– Viral haemorrhagic septicaemia  
– Infectious haematopoietic necrosis  
– Infection with highly polymorphic region (HPR) deleted Infectious salmon 
anaemia virus  
– Koi herpes virus  
– Infection with Mikrocytos mac kini 
– Infection with Perkinsus marinus  
– Infection with Bonamia ostreae  
– Infection with Bonamia exitiosa  
– Infection with Marteilia refringens   
EN 3  EN – Infection with Taura syndrome virus  
– Infection with yellow head virus  
– Infection with white spot syndrome virus   
EN 4  EN ANNEX II 
MINIMUM INFORMATION FOR DISEASE SURVEILLANCE PROGRAMME S  
(referred to in Article 10 ) 
The submission of a disease  surveillance programme  should include at least the following 
information:  
(a) a description of the epidemiological situation of the disease before the date of 
beginning of the implementation of the surveillance programme , and data on the 
epidemiological evoluti on of the disease;  
(b) the targeted animal population, epidemiological units an d zones of the surve illance 
programme;  
(c) the organisation of the competent authority, supervision of the implementation of the 
surveillance programme and official controls to be applied during the 
implementation of the programme and the role of all relevant operators, animal 
health professionals, veterinarians, animal health laboratories and other natural or 
legal person concerned ; 
(d) a description and demarcation of the geographical and administrative areas in which 
the surveillance programme is to be implement ed; 
(e) the indicators to measure the progress of the programme;  
(f) the diagnostic methods to be used, the number of samples to be tested, and the 
frequency of testing and sampling patterns;  
(g) the risk factors to be considered for the design of risk based targeted surveillance.   
EN 5  EN ANNEX III 
Table 1. Requirements as regards the residency periods for ungulates, bees and bumblebees before their entry into the Union  
Species and category of animals  Minimum residency period in the 
third country or territory of origin 
or zone thereof, as referred to 
Article 11(2)(a)  Minimum residency period in the 
establishment of origin, as referred 
to in Article 11(2)(b)  Minimum period without contact 
with animals of  a lower health 
status  as referred to in Article 
11(2)(c)  
Bovine, ovine, caprine and 
porcine animals  6 months or since birth, if the 
animals are less than 6 months of 
age 40 days, or since birth, if the animals 
are less than 40 days of age  30 days, or since birth, if the 
animals are less than 30 days of 
age 
Bovine, ovine, caprine and 
porcine animals intended for 
slaughter  3 months, or since birth if the 
animals are less than 3 months of 
age 40 days, or since birth, if the animals 
are less than 40 days of age  30 days, or since birth, if the 
animals are less than 30 days of 
age 
Equine animals  other than 
registered horses intended for 
competition, races or invited  
for specific cultural events  3 months, or since birth if the 
animals are less than 3 months of 
age  30 days  or since birth, if the animals 
are less than 30 days of age  15 days  
Registered horses intended for 
competition, races or invited  
for specific cultural events  40 days  40 days  40 days  
Ungulates other than bovine, 
ovine, caprine, porcine and 
equine animals  6 months or since birth, if the 
animals are less than 6 months of 
age 40 days, or since birth, if the animals 
are less than 40 days of age  6 months or since birth, if the 
animals are less than 6 months of 
age 
Honeybees and bumblebees  Since hatching  Since hatching  Since hatching   
EN 6  EN Table 2. Requirements as regards  the residency periods of poultry and captive birds before their entry into the Union  
Category of birds  The 
residency 
period 
applies 
to Minimum residency period in the 
third country or territory of origin 
or zone thereof, as referred to 
Article 11(2)(a)  Minimum residency period in 
the establishment of origin, as 
referred to Article 11(2)(b)  Minimum per iod without contact 
with animals of a lower health 
status as referred to in Article 
11(2)(c)  
Breeding poultry  AC 3 months or since hatching, if the 
animals are  less than 3 months of 
age 6 weeks, or since hatching, if 
the animals are  less than 6 
weeks of age 6 weeks, or since hatching, if the 
animals are  less than 6 weeks of 
age 
Productive poultry for the 
production of meat and 
eggs for consumption  AC 3 months, or since hatching, if the 
animals are  less than 3 months of 
age 6 weeks, or since hatching, if 
the animals are  less than 6 
weeks of age  6 week, or since hatching, if the 
animals are  less than 6 weeks of 
age 
Productive poultry for 
restocking supplies of game 
birds  AC 6 weeks, or since hatching, if the 
animals are  less than 6 weeks of 
age 
 30 days, o r since hatching  30 days, or since hatching   
 
Poultry  intended for 
slaughter  AC 6 weeks, or since hatching, if the 
animals are  less than 6 weeks of 
age 
 30 days, or since hatching   30 days, or since hatching  
 
 
Day-old chicks  AC Since hatching  Since hatching  Since hatching  
FO 3 months  6 weeks  - 
Less than 20 breeding 
poultry, productive poultry 
and poulry intended for 
slaughter other than ratites  AC l3 months, or since hatching, if 
the animals are  less than 3 months 
of age  3 weeks, or since hatching, if 
the animals are  less than 3 
weeks of age  3 weeks, or since hatching, if  the 
animals are  less than 3 weeks of 
age 
Less than 20 day-old chicks AC Since hatching  Since hatching  Since hatching   
EN 7  EN other than ratites  
FO 3 months  3 weeks  3 weeks prior to the date of 
collection of the eggs from which 
the day -old chicks have been 
hatched  
Captive birds  AC - 3 weeks or since hatching   3 weeks, or since hatching, if the 
animals are less than 3 weeks of 
age 
AC = Animals of the consignment  
FO = Flock of origin   
EN 8  EN ANNEX IV 
PART A 
1. Minimum periods  in months of disease  freedom of the third country or territory of origin  or zone thereof , as provided for in Article 
22(1) for ungulates other than equine animals  : 
 
1.Bovine 
animals  2. Ovine 
animals  3. Caprine 
animals  4. Porcine 
animals  5. Camelid 
animals  6. Cervid 
animals  7. Ungulates 
other than those 
referred to in 
columns 
1,2,3,4,5,6,*  
Foot and mouth disease  24 m**  24 m**  24 m**  24 m**  24 m**  24 m**  24 m**  
Infection with rinderpest 
virus  12 m  12 m  12 m  12 m  12 m  12 m  12 m  
Rift Valley fever virus  12 m  12 m  12 m  NA 12 m  12 m  12 m  
Contagious bovine 
pleuropneumonia  12 m  NA NA NA NA NA 12 m  
Peste des petits ruminants  NA 12 m  12 m  NA 12 m  12 m  NA 
Sheep pox and  goat pox  NA 12 m  12 m  NA NA NA NA 
Contagious caprine 
pleuropneumonia  NA 12 m  12 m  NA NA NA 12 m  
African swine fever  NA NA NA 12 m  NA NA NA 
Classical swine fever  NA NA NA 12 m ** NA NA 12 m  
Lumpy skin disease  12 m  NA NA NA NA NA NA 
* only applicable for listed species in accordance with the Annex  to Regulation (EU) 2018/1882   
** or specific conditions are provided by the competent authority of the third country or territory in accordance with Part B  as provided for in 
Article 22(3)   
EN 9  EN NA = not applicable   
EN 10  EN 2. Minimum periods in months of disease  freedom of the third country or territory of origin or zone thereof  in accordance with Article 
22(2)(a)  for equine animals : 
African horse sickness  24 m  
3. Minimum periods in months  without a case or outbreak of disease  reported in the third country or territory of origin or zone thereof in 
accordance with Article 2 2(2)(b)  for equine  animals : 
Venezuelan equine encephalomyelitis  24 m  
Infection with Burkholderia mallei  
(Glanders) ** 36 m  
Dourine ** 24 m  
Surra ( Trypanosoma evansi )** 24 m  
 
** or specific conditions are provided by the competent authority of the third country or territory in accordance with Part B as provided for in Article 
22(3)   
EN 11  EN PART B 
Specific conditions  to be provided by the competent authority of the third country or territory where the third country  or territory or zone  thereof  
has been free from certain diseases for less than the period set out in the table in Part A of this Annex as referred to in  Article 2 2(3): 
Foot and mouth disease  Supplementary information to determine the date from which the third country or territory or zone thereof is 
considered to be free from foot and mouth disease.  
Classical swine fever  (a) supplementary information  to determine the date from which the third country  or territory or zone thereof is 
considered to be free from classical swine fever ;  
(b) the animals intended for entry into the Union have reacted negatively to tests for classical swine fever, carried out 
within a period of 30 days prior to the date of dispatch to the Union.  
Infection with 
Burkholderia mallei  
(Glanders)  (a) no case or o utbreak has been reported in the establishment  of origin during a period of at least 6 months  prior to 
the date of dispatch to the Union ;  
(b) the Commission  has recognised  the surveillance programme carried out in breeding equine animals in the 
establishment of origin  to demonstrate absence of infection during that period  of 6 months .  
Dourine  (a) there has been no case or outbreak of the disease  in the establishme nt of origin  for a period at least 6 months  prior 
to the date of dispatch to the Union ;  
(b) the Commission  has recognised  the surveillance programme carried out to demonstrate the absence of infection in 
the establishment  of origin during that period  of 6 months . 
Surra ( Trypanosoma 
evansi ) (a) there has been no case or outbreak of surra ( Trypanosoma evansi ) in the establishment  of origin for a period of at 
least the 6 months  prior to the date of dispatch to the Union ;  
(b) the Commission  has recognised  the surveillance programme carried out to demonstrate the absence of infection in 
the establishment  of origin during that period  of 6 months .  
EN 12  EN PART C 
1. Requirements as regards the absence of vaccination for the third country  or territory of origin or zone thereof and for the ungulates other 
than equine animals  as referred to in Article 22(4)(a) : 
 1.Bovine 
animals  2. Ovine 
animals  3. Caprine 
animals  4. Porcine 
animals  5. Camelid 
animals  6. Cervid 
animals  7. Ungulates 
others than 
those referred 
to in columns  
1,2,3,4,5,6*  
Foot and mouth disease  NV/ NVA  NV/ NVA  NV/ NVA  NV/ NVA  NV/ NVA  NV/ NVA  NV/ NVA  
Rift Valley fever virus  NV/ NVA  NV/ NVA  NV/ NVA  NA NV/ NVA  NV/ NVA  NV/ NVA  
Contagious bovine 
pleuropneumonia  NV/ NVA  NA NA NA NA NA NV/ NVA  
Peste des petits ruminants  NA NV/ NVA  NV/ NVA  NA NV/ NVA  NV/ NVA  NA 
Sheep pox and goat pox  NA NV/ NVA  NV/ NVA  NA NA NA NA 
Contagious caprine 
pleuropneumonia  NA NV/ NVA  NV/ NVA  NA NA NA NV/ NVA  
Classical swine fever  NA NA NA NV/ NVA  NA NA NA 
Lumpy skin disease  NVA  NA NA NA NA NA NA 
NV = for a period of at least 12 months prior to the date of dispatch to the Union , no vaccination has been carried out in the third country, territory or zone 
and no vaccinated animals entered into the third country territory or zone   
NVA = the animals intended for the entry into the Uni on have not been vaccinated  
NA = not applicable  
* only applicable for listed species in  accordance with  the Annex to Regulation (EU) 2018/1882   
EN 13  EN 2. Requ irements as regards the absence of vaccination for the third country  or territory of origin or zone thereof and for the equine animals  as 
referred to in Article 22(4)(b) : 
African horse sickness  - No systematic vaccination has been carried out in in the third country  
or territory of origin or zone  thereof  during a period of at least 12 
months prior to the  date of dispatch to the Union  and the equine 
animals have not been vaccinated  at least in the last 40 days prior to 
dispatch to the Union  
Venezuelan equine encephalomyelitis  - The equine animals have not been vaccinated  at least in the last 6 0 days 
prior  to dispatch to the Union    
EN 14  EN ANNEX  V 
REQUIREMENTS  FOR  THE  ENTRY  INTO  THE  UNION  AS REGARDS  THE  DISEASE  
FREEDOM  OF THE  THIRD  COUNTRY  OR TERRITORY  OF ORIGIN  OR ZONE  THEREOF  
FROM  INFECTION  WITH  MYCOBACTERIUM  TUBERCULOSIS  COMPLEX  (M. BOV IS, 
M.CAPRAE,  M. TUBERCULOSIS ) AND  INFECTION  WITH  BRUCELLA  ABORTUS,  B. 
MELITENSIS  AND  B. SUIS  
1. INFECTION WITH MYCOBACTERIUM TUBERCU LOSIS COMPLEX (M. BOVIS , M.CAPRAE  
AND  M. TUBERCULOSIS )(AS REFERRED TO IN ARTICLE 22(5))  
1.1. Bovine animals  
Where b ovine animals do not originate from a third country or territory  or zone 
thereof  free of Mycobacterium tuberculosis complex (M. bovis, M.caprae, M. 
tuberculosis)  as regards bovine animals, they must comply with  one of the following  
requirements :  
(a) they have been test ed with one of the diagnostic methods provided for in Part 2 
of Annex 1  to Regulation (EU) 2019/…  as regards animal health requirements 
for movements within the Union of terrestrial animals and hatching eggs  
[document C(2019)4058]  for infection with  Mycobacterium tuberculosis 
complex  (M. bovis, M. caprae and M. tuberculosis) , with negative results, 
during the  period of 30 days prior to the date of dispatch  to the Union ; or 
(b) they are less than six weeks old.  
2. INFECTION WITH BRUCELLA  ABORTUS , B. MELI TENSIS  AND B. SUIS(AS REFERRED TO 
IN ARTICLE 22(6))  
2.1. Bovine animals  
Where bovine animals do not originate from a third country or territory or zone 
thereof free of Brucella  abortus, B. melitensis  and B. suis  without vaccination as 
regards bovine animals, they must comply with one of the following  requirements :  
(a) they have been tested with one of the diagnostic methods provided for in  Part 1  
of Annex I  to Regulation (EU) 2019 /… as regards animal health requirements 
for movements within the Union of terrestrial animals and hatching eggs  
[document C(2019)4058]  for infection with  Brucella  abortus, B. melitensis and 
B. suis , with negative results, on a sample taken during the period  of 30 days 
prior to the date of dispatch  to the Union, and in the case of post -parturient 
females, the test has been carried out on a sample taken at least 30 days after 
parturition ; or 
(b) they are  less than 12 months old; or  
(c) they are castrated.  
2.2. Ovine and caprine animals  
Where ovine and caprine animals do not originate from a third country or territory  or 
zone thereof free of  Brucella ( B.abortus , B. melitensis  and B. suis ) without 
vaccination as regards ovine and caprine animals , they must comply with one of the 
following  requirements :   
EN 15  EN (a) they have been tested with one of the diagnostic methods provided for in  Part 1 
of Annex I to Regulation (EU) 2019/…  as regards animal health requirements 
for movements within the Union of terrestrial animals an d hatching eggs  
[document C(2019)4058 ] for infection with  Brucella abortus, B. melitensis and 
B. suis , with negative results, on a sample taken during the period of 30 days 
prior to the date of dispatch  to the Union, and in the case of post -parturient 
fema les, the test has been  carried out on a sample taken at least 30 days after 
parturition; or  
(b) they are less than 6 months old; or  
(c) they are castrated.   
EN 16  EN ANNEX VI 
PART A 
SPECIFIC CONDITIONS  FOR THE ENTRY INTO THE UNION OF UNGULATES AS 
REGARDS THE DISEASE FREEDOM OF THE THIRD  COUNTRY OR TERRITORY  OF 
ORIGIN OR ZONE THERE OF FOR INFECTION WIT H BLUET ONGUE VIRUS (SEROTYPE 1-
24)  
(AS REFERRED TO IN ARTICLE 22(7))  
Where u ngulates of listed species do not originate  from a third country or territory or zone 
thereof  free from infection with bluetongue virus (serotypes 1 -24), they  must originate  from a 
third country or territory or zone thereof which complies  with at least one of the following 
requireme nts: 
(a) the animals have been kept in a third country or territory or zone thereof  seasonally 
free from infection with bluetongue virus (serotypes 1 -24) as defined in  Regulation 
(EU) 2019/…  as regards rules for surveillance, eradication programmes, and 
diseas e-free status for certain listed and emerging diseases  [document C(2019)4056] 
: 
(i) for a period of at least 60 days prior to the date of dispatch to the Union ;  
(ii) for a period of at least 28 days prior to the date of dispatch to the Union , and 
were subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the entry of the animal 
into the seasonally free from infection with bluetongue virus (serotypes 1 -24) 
free third coun try or territory or zone  thereof ; or 
(iii) for a period of at least 14 days prior to the date of dispatch to the Union , and 
were subjected to a  polymerase chain reaction  (PCR ) test, with negative 
results, carried out on samples collected at least 14 days f ollowing the date of 
entry of the animal in to the seasonally BTV free third country or territory or 
zone  thereof . 
(a) the animals originate from a third country, territory or zone thereof with a  
surveillance system in place designed and implemented in accordan ce with Sections  
1 and  2 of Chapter 1, Part II of Annex to Regulation (EU) 2019/…  as regards rules 
for surveillance, eradication programmes, and disease -free status for certain listed 
and emerging diseases  [document C(2019)4056]  and have been vaccinated ag ainst 
all the serotypes (1 to 24 ) of bluetongue virus reported during the preceding two 
years in that third country , territory  or zone  thereof and the animals are still within 
the immunity period of time guaranteed in the specifications of the vaccine , and the 
animals  comply with at least one of the following requirements:  
(i) they have been vaccinated more than 60 days prior to the date of dispatch to 
the Union ; or 
(ii) they have been vaccinated with an inactivated vaccine and were subjected to a 
PCR test,  with negative results on samples collected at least 14 days after the 
onset of the immunity protection set in the specifications of the vaccine . 
(b) the animals originate from a third country, territory or zone thereof with a 
surveillance system in place desi gned and implemented in accordance with Sections 
1 and 2 of Chapter 1, Part II of Annex to Regulation (EU) 2019/…  as regards rules 
for surveillance, eradication programmes, and disease -free status for certain listed  
EN 17  EN and emerging diseases  [document C(2019)4 056] and the animals were subjected 
with positive results to a serological test able to detect specific antibodies against all 
serotypes (1-24) bluetongue virus reported during the preceding two years in that 
third country or territory or zone  thereof , and: 
(i) the serological test must have been carried out on samples collected at least 60 
days prior to the date of movement;  
or 
(ii) the serological test must have been carried out on samples collected at least 30 
days prior to the date of the movement and the animals were subjected to a 
PCR test, with negative results, carried out on samples collected not earlier 
than 14 days prior to the date of dispatch to the Union . 
PART B 
SPECIFIC CONDITIONS FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF 
BOVINE ANIMALS  AS REGARDS THE DISEA SE FREEDOM OF THE TH IRD COUNTRY OR 
TERRITORY OF ORIGIN OR ZONE THEREOF FOR ENZOOTIC BOVINE LEUK OSIS   
(AS REFERRED TO IN ARTICLE 22(8))  
Where b ovine animals do not originate from  a third country or territory or zone thereof free of 
enzo otic bovine leu kosis, they  must come from a third country or territory or zone thereof 
where that disease  has not been reported during the period of 24 months prior to the date of 
loading for dispatch  to the Union , and : 
(a) animals over the age of 24 months have been subjected to a laboratory examination  
for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 
4 of Annex I  to Regulation (EU) 2019/… as regards animal health requirements for 
movements within the Union of terrestrial a nimals and hatching eggs  [document 
C(2019)4058 ], with negative results, carried out on samples taken on two occasions 
at an interval of at least four months while kept  in isolation from the other bovine 
animals of the same establishment , during the period of 12 months prior to date of 
dispatch  to the Union ; or 
(b) animals less than 24 months of age, originate from 'uterine' mothers (dams), which 
have been subjected to a laboratory examination for enzootic bovine leukosis with 
one of the diagnostic methods provi ded for in Part 4 of Annex I  to Regulation (EU) 
2019/… as regards animal health requirements for movements within the Union of 
terrestrial animals and hatching eggs  [document C(2019)4058 ] with negative 
results, carried out on samples taken during the period of 12 months prior to the date 
of dispatch  to the Union on two occasions at an interval of not less than four months.   
EN 18  EN ANNEX VII 
ADDITIONAL  REQUIREMENTS  FOR  THE  ENTRY  INTO  THE  UNION  OF UNGULATES  AS 
REGARDS  THE  DISEASE  OF THE  THIRD  COUNTRY  OR TERRITORY  OF ORIGIN  OR 
ZONE  THEREOF  AS REGARDS  CERTAIN  CATEGORY  C DISEASES   
(AS REFERRED  TO IN ARTICLE  22(9))  
1. INFECTIOUS BOVINE RHI NOTRACHEITIS /INFECTIOUS PUSTULAR VULVOVAGINITIS  
1.1. Bovine animals  
The animals must have been subject to quarantine  for a period of at least 30 days 
prior to the date of dispatch  to the Union  and have been subjected to a serological 
test for the detection of antibodies against whole BoHV -1 or, in case of DIVA -
vaccinated animals, antibodies against BoHV -1-gE, with one of the diagnostic 
methods provided for in Part 5  of An nex I  to Regulation (EU) 2019/…  as regards 
animal health requirements for movements within the Union of terrestrial animals 
and hatching eggs  [document C(2019)4058 ], with a negative result, on a sample 
collected in the establishment of origin within the period of 15 days prior to  the date 
of dispatch for the Union . 
1.2. Camelid and c ervid animals  
In case that camelid and cervid  animals are intended for entry into  a Member State or 
zone thereof with disease -free status or with an approved eradication programme 
regarding  infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in 
bovine animals, they must come from an establishment in which no infectious  bovine 
rhinotracheitis/infectious pustular vulvovaginitis has been reported on cervid animals 
the last 30 days prior to departure.  
2. BOVINE VIRAL DIARRHOE A 
The animals must have been tested for bovine viral diarrhoea virus antigen or 
genome with one of the diagnostic methods provided for in Part 6 of Annex I  to 
Regulation (EU) 2019/… as regards animal health requirements for movements 
within the Union of terrestrial animals and hatching eggs  [document C(2019)4058 ], 
with negative results, and either : 
(a) the animals have been kept in an approved quarantine establishment for a 
period of at least 21 days prior to their departure and, in case of pregnant dams, 
they have been subjected to a serological test for the detection of antibodies 
against bovine viral diar rhoea virus with one of the diagnostic methods 
provided for in Part 6 of Annex I, with negative results, carried out on samples 
taken not less than 21 days after commencement of the quarantine; or  
(b) the animals have been subjected to a serological test for the detection of 
antibodies against bovine viral diarrhoea virus with one of the diagnostic 
methods provided for in Part 6 of Annex I  to Regulation (EU) 2019/… as 
regards animal health requirements for movements within the Union of 
terrestrial animals and hatching eggs  [document C(2019)4058 ], with positive 
results, carried out on samples taken either prior to departure or, in case of 
pregnant dams, before insemination preceding the current gestation.   
EN 19  EN 3. INFECTION WITH AUJESZKY DISEASE VIRU S 
1. The animals must have been subjected to a serological test for the detection of 
antibodies against all Aujeszky’s disease virus  with one of the diagnostic 
methods provided for in  Part 7 of Annex 1  to Regulation (EU) 2019 /… as 
regards animal health requirements for mov ements within the Union of 
terrestrial animals and hatching eggs  [document C(2019)4058 ], with a 
negative result, on a sample collected in the establishment of origin during the 
period of 15 days prior to the date of their dispatch to the Union .  
2. For porcine animals less than 4 months of age  descending from DIVA -
vaccinated mothers , the serological test for the detection of antibodies against 
Aujeszky’s disease virus  gE protein provided for in  Section 6 of Annex Y of 
Regulation (EU) 2019 /… as regard s animal health requirements for 
movements within the Union of terrestrial animals and hatching eggs  
[document C(2019)4058 ] may be used  instead of the serological test referred to 
in point 1 .  
3. The number of porcine animals sampled for the serological te sts referred to in 
points 1 and 2 must allow at least for the detection of 10% seroprevalence of 
the consignment with a 95% confidence.   
EN 20  EN ANNEX  VIII  
ANIMAL HEALTH REQUIREMENTS AS REGARDS THE ESTABLISHMENT OF ORIGIN OF UNGULATES  
1. Minimum areas ( in radius) and periods ( in days)  without a reported case or outbreak of certain  diseases  in the area in and around the 
establishment of origin of the ungulates other than equine animals , as referred to in Article 23(1)(a)(i) : 
 1. Bovine 
anim als 2. Ovine 
animals  3. Caprine 
animals  4. Porcine 
animals  5. Camelid 
animals  6. Cervid 
animals  7. Ungulates 
others than  those 
referred to in 
columns  
1,2,3,4,5,6*  
Foot and mouth disease  10 km /  
30 days  10 km /  
30 days  10 km /  
30 days  10 km /  
30 days  10 km  / 
30 days  10 km /  
30 days  10 km /30 days  
Infection with rinderpest virus  10 km /  
30 days  10 km /  
30 days  10 km /  
30 days  10 km /  
30 days  10 km /  
30 days  10 km /  
30 days  10 km /30 days  
Rift Valley fever virus  10 km /  
30 days  10 km /  
30 days  10 km /  
30 days NA 10 km /  
30 days  10 km /  
30 days  10 km /30 days  
Contagious bovine 
pleuropneumonia  10 km /  
30 days  NA NA NA NA NA 10 km / 30 days  
Peste des petits ruminants  NA 10 km /  
30 days  10 km /  
30 days  NA 10 km /  
30 days  10 km / 30 days  NA 
Sheep pox and goat pox  NA 10 km /  
30 days  10 km /  
30 days  NA NA NA NA 
Contagious caprine 
pleuropneumonia  NA 10 km /  
30 days  10 km /  
30 days  NA NA NA 10 km /30 days  
African swine fever  NA NA NA 10 km /  
30 days  NA NA NA 
Classical swine fever  NA NA NA 10 km /  
30 days  NA NA NA 
Lumpy skin disease  10 km /  
30 days  NA NA NA NA NA NA  
EN 21  EN Infection with epizootic 
haemorrhagic disease virus  150 km/  
2 years**  150 km/  
2 years ** 150 km/  
2 years ** NA 150 km/  
2 years ** 150 km/  
2 years ** 150 km/  
2 years ** 
* only applicable for listed species in  accordance with  the Annex to Regulation (EU) 2018/1882  
** not applicable if the animals originate from a third country, territory or zone thereof seasonally free of the disease  in accordance with the relevant 
Chapter of the Terrestrial A nimal Health Code of the World Animal Health Organisation (OIE)  
2. Minimum periods  without a reported case or outbreak of certain diseases in the establishment of origin for ungulates other than equine 
animals  as referred to in Article 23(1)(a)(i) : 
 1. Bovine 
animals  2. Ovine 
animals  3. Caprine 
animals  4. Porcine 
animals  5. Camelid 
animals  6. Cervid 
animals  7. Ungulates 
others than those 
referred to in 
columns 
1,2,3,4,5,6*  
Burkholderia malle i 
(Glanders)  NA 6 months  NA Same as equine 
animals (point 4)  NA 
Rabies  30 days  
Surra ( Trypanosoma 
evansi ) 30 days**  30 days**  30 days**  NA 30 days** 30 days**  30 days**  
Anthrax  15 days  
Infection with Aujeszky’s 
disease virus  NA 30 days  NA 
* only applicable for listed species in accordance with  the Annex to Regulation (EU) 2018/1882  
** if a case or outbreak was reported in the establishment of origin during the period of 2 years prior to the date of dispatch  to the Union, following the 
last outbreak the affected establishment must have remained under restriction until:  
(a) the infected animals were removed from the establishment;  
(b) the remaining animals on the establishment were subjected with negative result to a test for surra ( Trypanosoma evansi ) as described in [ Part 3 of 
Annex I to regulation (EU) 2019/…  as regards animal health requirements for movements within the Union of terrestrial animals and hatching eggs  
[document C(2019)4058 ] carried out on samples taken at least 6 months after the infected animals were removed from the est ablishment.   
EN 22  EN 3. Minimum areas ( in radius) and periods ( in months)  without a reported case or 
outbreak of equine infectious anaemia in the area in and around the establishment of 
origin of  equine animals  as referred to in Article 23(1)(a)(ii):  
4. Minimum periods  without a reported case or outbreak of certain diseases in the 
establishment of origin for equine animals  as referred to in Article 23(1)(a)(ii) : 
 Period  Requirements to be compl ied with where the re has been a previous 
reported case or outbreak in the establishment  
Infection with 
Burkholderia 
mallei (Glanders)  6 m Where an infection was reported in  the establishment during the 
period of 3 years prior to the date of dispatch to the Union , 
following the last outbreak  the establishment remained under 
movement restriction s by the competent authority until:  
– the infected animals have been killed and destroyed ; and  
– the remaining animals were subjected to a te st carried out 
as described in point 1 of Annex XI of [document 
C(2019)4058 ] with negative results on samples taken at 
least 6 months after the date on which t he infected 
animals were  killed and destroyed and the establishment 
cleaned and disinfected  
Venezuelan equine 
encephalomyelitis  6m In case they come from an establishment situated in a third country, 
territory or zone thereof in which Venezuelan equine 
encephalomyelitis has been reported during the last 2 years  prior to 
the date of dispatch to the Union , they comply with the conditions 
in point (i) and the conditions in either of points (ii) or (iii):  
(i) during the period of at least 21 days prior to 
depa rture they have remained clinically healthy and any 
animal referred to in point (ii) or (iii) which showed a rise 
in body temperature, taken daily, have been subjected to a 
diagnostic test for Venezuelan equine encephalomyelitis 
with the diagnostic method provided for in point (a) of 
Part 10(1) of Annex I  of [document C(2019)4058 ], with 
negative results; and  
(ii) the animals were kept in quarantine for a period of 
at least 21 days protected from attacks by insect vector, 
and either  
– have been vaccinated against Venezuelan 
equine encephalomyelitis with a complete 
primary course and revaccinated according to 
manufacturer's recommendations not less 
than 60 days and not more than 12 months 
prior to the date of dispatch; or  
– have been subjected to a test for Ve nezuelan 
equine encephalomyelitis with the diagnostic  Area  Period  Requirements to be compl ied with where there has been a case or 
outbreak in the establishment  
Equine 
infectious 
anaemia  200 m  3 m1 All the equine animals  were isolated until they were subjected  a 
serological test for equine infectious anaemia carried out with 
negative results on 2 samples taken after the slaughter of the 
infected animal and 3 months apart   
EN 23  EN method provided for in point (b) of Part 10(1) 
of Annex I  of [document C(2019)4058 ], with 
negative results, carried out on a sample 
taken not less than 14 days after the date of 
entry into quarantine;  
(iii) the animals have been subjected to  
– a test for Venezuelan equine 
encephalomyelitis with the diagnostic 
method provided for in point (b) of Part 10(1) 
of Annex I  of [document C(2019)4058 ], 
without an increase in antibody titre, carried 
out on paired sa mples taken on two occasions 
with an interval of 21 days, the second of 
which was taken during a period of 10 days 
prior to the date of departure; and  
– a test for the detection of Venezuelan equine 
encephalomyelitis virus genome with the 
diagnostic method p rovided for in Part 10(2) 
of Annex I  [document C(2019)4058 ], with 
negative result, carried out on a sample taken 
within 48 hours prior to departure, and the 
animals have been protected from attacks by 
insect vectors after sampling until d eparture.  
 
Dourin e 6 m Where an infection was reported  in the establishment during the 
period of 2 years prior to  the date of dispatch to the Union , 
following the last outbreak  the establishment remained under 
movement restriction by the competent authority until:  
– the infected animals have been killed and destroyed or 
slaughtered, or the infected entire male equine animals 
have been castrated; and  
– the remaining equine animals in the establishment,  with 
the exception of the castrated male equine animals 
referred to in first indent  kept apart from female equine 
animals,  were subjected to a test for dourine with the 
diagnostic method provided for in Part 8 of Annex I of 
[document C(2019)4058 ] with negative results , carried 
out on samples taken at least 6 months after the measures 
described in the first indent have been completed.  
Surra  
(Trypanosoma 
evansi ) 6 m Where infection was reported in  the establishment during the period 
of 2 years prior to the date of dispatch to the Union, the 
establishment remained under movement restriction by the 
competent authority until:  
– the infected animals have been removed from the 
establishment ; and  
– the remaining animals have been  subjected to a test for 
surra ( Trypanosoma evansi ) with one of the diagnostic 
methods  provided for  in [Part 3 of Annex I of document 
C(2019)4058 ] with negative results , carried out  on 
samples taken at least 6 months after the last infected  
EN 24  EN animal  has been removed from the establishment . 
Equine infectious 
anemia  90 d Where an infection was reported  in the establishment during the 
period of 12 months  prior to the date of dispatch to the Union,  
following the last outbreak  the establishment remained under 
movement restriction by the competent authority until:  
– the infected animals have been ki lled and destroyed or 
slaughtered; and  
– the remaining animals in the establishment have been 
subjected to a test foe equine infectious anemia with the 
diagnostic method provided for in  Part 9 of Annex I of 
[document C(2019)4058 ] with negative results , carried 
out on samples taken on two occasions with a minimum 
interval of 3 months after the measures described in the 
first indent have been completed and the establishment 
was cleaned and disinfected.  
Rabies  30 d - 
Anthrax  15 d - 
  
EN 25  EN ANNEX IX 
1. INFECTION WITH MYCOBACTERIUM TUBERCU LOSIS COMPLEX  (M. BOVIS , 
M.CAPRAE  AND M. TUBERCULOSIS )(AS REFERRED TO IN ARTICLE 23(2))  
2. INFECTION WITH BRUCELLA  B. ABORTUS , B. MELITENSIS AND B. SUIS  (AS REFERRED 
TO IN ARTICLE 23(3))  Species  Requirements as regards the establishment of origin  
Bovine animals  Free as regards bovine animals  
Caprine animals  Subjected to a surveillance program me to detect infection in accordance 
with the procedures in [part 1 of Annex II  of Regulation (EU) 2019/… 
document C(2019)4058 ] during at least the last 12 months prior to dispatch 
to the Union and during this period : 
(a) no infection has been reported  in animals of the same species on 
the establishment during the period of 42 days prior to the date of 
dispatch to the Union;  
(b) no animals which do not fulfil the re quirement  set out in point (a) 
have been introduced into the establishment during the period of 
12 months prior to the date of dispatch  to the Union.  Camelid animals  
Cervid animals  
Species  Requirements as regards the establishment of origin  
Bovine animals  Free without vaccination as regards bovine animals  
Ovine animals  Free without vaccination as regards ovine and caprine animals  
Caprine animals  Free without vaccination as regards ovine and caprine animals  
Porcine animals  Biosecurity and risk mitigating measures are in place to prevent the 
transmission of infection from  wild animals of listed species likely to be 
infected  
Subjected to a surveillance program me to detect infection in accordance 
with the procedures i n [Part 1 of Annex I  of Regulation (EU) 2019/…  
document C(2019)4058 ] and compliance with the following requirements : 
(a) only animals from establishments in which a surveillance for 
infection with Mycobacterium tuberculosis complex  (M. bovis, M. 
caprae  and M. tuberculosis ) has been carried out on the animals 
kept on the establishment in accordance with [point 1 and 2 of 
Part 1 of Annex II Regulation (EU) 2019/… document 
C(2019)4058]  for at least the last 12 months prior to departure, 
can be introduced. During this period only caprine animals from 
establishments applying the measures provided for in this 
paragraph can be introduced in the establishments mentioned in 
this indent.  
(b) (ii) in case infection with Mycobacterium tuberculosis complex Camelid 
animals  
Cervid animals   
EN 26  EN (M. bovis, M. caprae and M. tuberculosis ) has been reported on 
the establishment, measures were taken in accordance with [part 
1(3) of Annex II  of Regulation (EU) 2019/… document 
C(2019)4058] .  
EN 27  EN ANNEX X 
SPECIFIC REQUIREMENTS  FOR ENTRY INTO THE UNION OF CERTAIN 
SPECIES AND CATEGORIES OF UNGULATES AS REGARDS INFECTION WITH 
BRUCELLA  AS REFERRED TO IN ARTICLE 2 4(5) 
1. OVINE ANIMALS :  
Uncastrated males of ovine animals must comply with the following requirements :  
(a) they have remained for a continuous period of at least 60 days in an 
establishment where no case or outbreak of infection with Brucella ovis  
(contagious epididymitis) has been reported during the period of 12 months 
prior to the da te of dispatch to the Union;  
(b) they have been subjected to a serological test for contagious epididymitis 
during the period of 30 days prior to the da te of dispatch to the Union.  
2. PORCINE ANIMALS AND U NGULATES OF THE FAMI LY TAYASSUIDAE  
Porcine animals and ungulates of the family Tayassuidae  must have been subjected 
during the period of 30 days prior to date of dispatch to the Union to a buffered 
Brucella antigen test for the detect ion of Brucella suis  with negative results.   
EN 28  EN ANNEX XI 
SPECIFIC REQUIREMENTS FOR EQUINE ANIMALS AS REFERRED TO IN 
ARTICLE 2 4(6) 
1. SANITARY GROUPS  TO WHICH THIRD COUNT RIES, TERRITORIES OR ZONES  THEREOF 
ARE ASSIGNED  
Sanitary 
Group  Diseases for which specific requirements are required  
A equine infectious anaemia  
B equine infectious anaemia, glanders, dourine   
C equine infectious anaemia, Venezuelan equine encephalomyelitis  
D equine infectious anaemia, glanders, dourine, Venezuelan equine encephalomyelitis, surra  
E equine infectious anaemia, glanders, dourine, African horse sickness, surra  
F equine infectious anaemia, dourine, African horse sickness  
G equine infectious anaemia, glanders, dourine, surra  
2. SPECIFIC REQUIREMENTS  
2.1. Specific requirements for African horse sickness:  
Equine animals must comply  with the set of requirements laid down in one of the 
following points : 
(a) the animals have been kept  in isolation in vector protected premises for a 
period of at lea st 40 days prior to the date of dispatch  to the Union ;  
(b) the animals have been kept in isolation in vector protected premises for a 
period of at least 30 days prior to the date of dispatch  to the Union  and have 
been subjected to  a serological test , carried out by the same laboratory on the 
same day on blood samples taken during the isolation period in vector 
protected premises on two occasions with an interval of between 21 and 30 
days, the second of which must have been taken within a period of 10  days 
prior to the date of dispatch, with negative results in each case or with negative 
result in an agent identification test on the second sample ; 
(c) the animals have been kept in isolation in vector protected premises for a 
period of at least 30 days prior to dispatch to the Union and prior to the date of 
a serological and an agent identification test for African horse sickness, carried 
out with negative result in each case on a blood sample taken not less than 28 
days after the date of introduction  into the vector -protected quarantine and 
within a period of 10 days prior to the date of dispatch;  
(d) the animals have been kept in isolation in vector protected premises for a 
period of at least 14 days prior to dispatch and prior to an agent identificati on 
test for African horse sickness, carried out with negative result on a blood 
sample taken not less than 14 days  after the date of introduction into the vector -
proof qua rantine and not more than 72 hours before the time of dispatch.   
EN 29  EN 2.2. Specific requirements  for Venezuelan equine encephalomyelitis  
Equine animals must comply with the set of requirements laid down in one of the 
following points : 
(a) the animals:  
(i) have been vaccinated against Venezuelan equine encephalomyelitis with 
a complete primary course and revaccinated in accordance with the 
manufacturer's recommendations during a period of not less than 60 days 
and no t more than 12 months prior to the date of  dispatch to the Union ; 
(ii) have been kept in vector -protected quarantine for a period of at least 21 
days prior to the date of dispatch  to the Union , and during that period 
they have remained clinically healthy, and their body temperature, taken 
daily, has remained within the normal physiological range ; 
(iii) any equine animal on the same holding which showed a rise in body 
temperature, taken daily, was subjected to a blood test for virus isolation 
for Venezuelan equine encephalomyelitis with negative res ults;  
or 
(b) the animals:  
(i) have not been vaccinated against Venezuelan equine encephalomyelitis ; 
(ii) have been and was kept in vector -protected quarantine for a period of at 
least 21 days, and during that period they have remained clinically 
healthy, and their body temperature, taken daily, has remained within the 
normal physiological range ; 
(iii) any equine animal on the same holding which showed a rise in body 
temperature, taken daily, was subjected to a blood test for virus isolation 
for Venezuelan equine encephalomyelitis with negative results ;  
(iv) the animal s to be dispatched to the Union were  subjected to a diagnostic 
test for Venezuelan equine encephalomyelitis with negative result s 
conducted on a sample taken not less than 1 4 days after the date of entry 
of the animals into the vector -protected quarantine and the animals have 
remained protected from vector insects until dispatch;  
or 
(c) the animals have been subjected to a haemagglutination inhibition test for 
Venezuelan equ ine encephalomyelitis carried out by the same laboratory on the 
same day on samples taken on two occasions with an interval of 21 days, the 
second of which was taken during a period of 10 days prior to the date of 
dispatch, without an increase in antibody titre, and a RT -PCR (reverse 
transcription -polymerase chain reaction) test for the detection of Venezuelan 
equine encephalomyelitis virus genome, carried out with negative result on a 
sample taken within 48 hours prior to dispatch, and has been protected f rom 
vector  attacks from the moment of the RT -PCR sampling until loading for 
dispatch, by combined use of approved insect repellents and insecticides on the 
animal and disinsection of the stable and the m eans in which it is transported.   
EN 30  EN 2.3. Specific requirement s for glanders  
Equine animals  must have been subjected to a complement fixation test for glanders 
as described in point 3.1. of Chapter 2.5.11 of the OIE Terrestrial Manual (Version 
adopted 2015) carried out with negative result s at a serum dilution of 1 i n 5 on a 
blood sample taken within a period of 30 days prior to the date of dispatch  to the 
Union . 
2.4. Specific requirements  for dourine  
Equine animals  must have been subjected to a complement fixation test for dourine 
as described in point 3.1. of Chapter 2.5.3 of the OIE Terrestrial Manual (Version 
adopted 2013) carried out with negative result s at a serum dilution of 1 in 5 on a 
blood sample taken within a period of 30 days prior to the date of dispatch  to the 
Union , and not have been used for breeding during the period of at least 30 days 
prior to and after the date the sample was taken.  
2.5. Specific conditions for surra  
Equine animals  must have been subjected to a card agglutination test for 
trypanosomiasis (CATT) as described in point 2.3. of Chapter 2.1.21 of the OIE 
Terrestrial Manual (Version adopted 2012) carried out with negative result s at a 
serum dilution of 1 in 4 on a blood sample taken within a perio d of 30 days prior to 
the date of dispatch  to the Union . 
2.6. Specific conditions  for equine infectious anaemia  
Equine animals  must have been subjected with negative result s to an agar gel 
immunodiffusion test (AGID or Coggins test) or to an ELISA for equine in fectious 
anaemia as described in point 2.1. or 2.2. of Chapter 2.5.6 of the OIE Terrestrial 
Manual (Version adopted 2013) carried out on a blood sample taken within a period 
not exceeding 90 days prior to the date of dispatch  to the Union .  
EN 31  EN ANNEX XII 
UNGULATES INTENDED FOR CONFINED ESTABLISHMENTS  
PART A: Minimum periods  (in months) without a reported case or outbreak of disease in the confined establishment of origin  of the ungulates intended for 
confined establishments  in the Union : 
 
1.Bovine 
animals  2. Ovine 
animals  3. Caprine 
animals  4. Porcine 
animals  5. Camelid 
animals  6. Cervid 
animals  7. Ungulates 
others than  
those referred 
to in columns  
1,2,3,4,5,6,7*  
Foot and mouth disease  6 m 6 m 6 m 6 m 6 m 6 m 6 m 
Rift Valley fever virus  6 m 6 m 6 m NA 6 m 6 m 6 m 
Contagious bovine pleuropn.  6 m NA NA NA NA NA 6 m 
Peste des petits ruminants  NA 6 m 6 m NA 6 m 6 m NA 
Sheep pox and goat pox  NA 6 m 6 m NA NA NA NA 
Contagious caprine pleuropn.  NA 6 m 6 m NA NA NA 6 m 
African swine fever  NA NA NA 6 m NA NA NA 
Classical swine fever  NA NA NA 6 m NA NA NA 
Lumpy skin disease  6 m NA NA NA NA NA NA 
Burkholderia mallei  (Glanders)  NA NA 6 m NA 6 m NA NA 
Brucella (B. abortus, B. melitensis and B. suis ) 6 m 6 m 6 m 6 m 6 m 6 m 6 m 
Mycobacterium tuberculosis complex  (M. bovis, 
M. caprae, M. tuberculosis ) 6 m 6 m 6 m 6 m 6 m 6 m 6 m 
Rabies  6 m 6 m 6 m 6 m 6 m 6 m 6 m 
Surra ( Trypanosoma evansi ) 30 days  30 days  30 days  NA 180 days  30 days  30 days  
Anthrax  30 days  30 days  30 days  30 days  30 days  30 days  30 days  
Infection with bluetongue virus (Serotypes 1 -24) 6 m 6 m 6 m NA 6 m 6 m 6 m  
EN 32  EN Aujeszky's disease virus  NA NA NA 12 m  NA NA NA 
* only applicable for listed species in accordance with  the Annex to Regulation (EU) 2018 /1882   
EN 33  EN PART B: Minimum areas ( in radius) and periods without a reported case or outbreak of certain  diseases in the area around the confined 
establishment of origin of the ungulates intended for confined establishments  in the Union : 
 1.Bovine 
animals  2. Ovine 
animals  3. Caprine 
animals  4. Porcine 
animals  5. Camelid 
animals  6. Cervid 
animals  7. Ungulates 
others than  
those  referred to 
in column 
1,2,3,4,5,6,7*  
Foot and mouth disease  10 km /  
30 days  10 km /  
30 days  10 km /  
30 days  10 km /  
30 days  10 km /  
30 days  10 km /  
30 days  10 km /30 days  
Rift Valley fever virus  150 km /  
30 days  150 km /  
30 days  150 km /  
30 days  NA 150 km /  
30 days  150 km /  
30 days  150 km /  
30 days  
Contagious bovine 
pleuropneumonia  10 km /  
30 days  NA NA NA NA NA 10 km /  
30 days  
Peste des petits ruminants  NA 10 km /  
30 days  10 km /  
30 days  NA 10 km /  
30 days  10 km /  
30 days  NA 
Sheep pox and goat pox  NA 10 km /  
30 days  10 km /  
30 days NA NA NA NA 
Contagious caprine 
pleuropneumonia  NA 10 km /  
30 days  10 km /  
30 days  NA NA NA 10 km /  
30 days  
African swine fever  NA NA NA 10 km /  
12 m NA NA NA 
Classical swine fever  NA NA NA 10 km /  
12 m  NA NA NA 
Lumpy skin disease  150 km /  
30 days  NA NA NA NA NA NA 
Infection with bluetongue 
virus (Serotypes 1 -24) 150 km /  
30 days  150 km /  
30 days  150 km /  
30 days  NA 150 km /  
30 days  150 km /  
30 days  150 km /  
30 days  
Epizootic haemorrhagic 
disease  150 km /  
30 days  150 km /  
30 days  150 km /  
30 days  NA 150 km /  
30 days  150 km /  
30 days  150 km /  
30 days   
EN 34  EN Aujeszky's disease virus  NA NA NA 5 km /12 m **  NA NA NA 
* only applicable for listed species in accordance with the Annex to Regulation (EU) 2018   
EN 35  EN ** in addition, a  virology and serology test must be carried out to rule out the presence of the disease  30 days prior to dispatch  to the Union   
EN 36  EN PART C 
Minimum periods of disease freedom  (in months) of the third country  or territory or  zone thereof where the confined establishemnt of origin is 
located for ungulates intended for confined establishments  in the Union : 
 
1.Bovine 
animals  2. Ovine 
animals  3. Caprine 
animals  4. Porcine 
animals  5. Camelid 
animals  6. Cervid 
animals  7. Ungulates 
others than 
those referred to 
in columns 
1,2,3,4,5,6,7*  
Foot and mouth disease  12 m**  12 m**  12 m**  12 m**  12 m**  12 m**  12 m**  
Infection with rinderpest virus  12 m  12 m  12 m  12 m  12 m  12 m  12 m  
Rift Valley fever virus  48 m**  48 m**  48 m**  NA 48 m**  48 m**  48 m**  
Epizootic haemorrhagic 
disease  24m**  24m**  24m**  NA 24m**  24m**  24m**  
African swine fever  NA NA NA 12 m*  NA NA NA 
Classical swine fever  NA NA NA 12 m*  NA NA NA 
Brucella (B. abortus, B. 
melitensis and B. suis ) 12 m **  12 m **  12 m ** 12 m **  12 m **  12 m **  12 m **  
Infection with bluetongue 
virus (Serotypes 1 -24) 24m**  24m**  24m**  NA 24m**  24m**  24m**  
* only applicable for listed species in accordance with the Annex to Regulation (EU) 2018  
** or supplementary  guarantees  are provided by the competent authority of the third country or territory according to Part B   
EN 37  EN PART D 
Supplementary guarantees  to be provided by the competent authority of the third country or territory as regards certain listed diseases  
Foot and mouth 
disease  (a) the animals have been subjected to a serological test for evidence of foot and mouth disease virus infection carried out in accordance with one of 
the prescribed tests for international trade laid down in the OIE Manual of Diagnostic Tests and Vaccines for T errestrial Animals (OIE Terrestrial 
Manual), with negative results, taken within a period of  10 days prior to the date of dispatch to the Union ; and 
(b) for Bovidae, Cervidae  and Elephas spp.: a probang test for evidence of foot and mouth disease virus infection carried out in accordance with the 
procedures laid down in the  OIE Terrestrial Manual, with negative results. The test must have been taken:  
(i) 10 days prior to the date of  dispatch to the Union, for species other than African buffalo ( Synercus caffer ); 
(ii) on two occasions 15 days  at least apart, the second of which must have been taken during the period of 10 days prior to the date of 
dispatch to the Union, for African buffalo ( Synercus caffer ). 
Rift Valley fever 
virus  (a) the animals  must : 
(i) have been kept in quarantine in a vector  protected facility in the approved confined establishment for a period of at least 30 days prior to 
the date of dispatch to the Union ;  
(ii) have showed no clinical signs of infection with Rift valley fever virus for a period of at least 30 days prior to the da te of dispatch to the 
Union ;  
(iii) have been protected from vectors when transported between the vector protected facility referred to in point (i) and loading for dispatch 
to the Union . 
(b) the animals have been subjected to a virus neutralisation test with negative results for evidence of infection with Rift valle y fever virus in 
accordance with the OIE Terrestrial Manual, taken firstly at the date of commencement of the quarantine period and  secondly at least 42 days 
from that that date and and during  a period of 10 days prior to the dispatch to the Union.  
African swine fever  The animals have been subjected to a virology and serology test for the detection of African swine fever  and classical swine fever  in accordance 
with the test prescribed for international trade in the OIE Terrestrial Manual, taken during the period of 30 days prior to the date of dispatch to the 
Union.  Classical swine fever  
Brucella (B. abortus, 
B. melitensis and B. 
suis) (a) the animals have been subjected to a test as laid down and prescribed for international trade by the OIE Terrestrial Manual, during the period of 
the 30 days prior to the date of dispatch to the Union, or  
(b) they are castrated males of any age  
Infection with 
bluetongue virus 
(Serotypes 1 -24) The animals must  comply with the requirements set out in one of the following points : 
(a) they have been kept in quarantine in a vector -protected facility in the confined establishment for a period of at leas t 30 days prior to the date 
of dispatch to the Union and have been subjected to a serology test for infection with bluetongue  virus (1 -24) and infection with epizootic 
haemorrhagic disease virus  carried out in accordance with  the OIE Terrestrial Manual wit h negative results, carried out at least 28 days after the 
introduction of the animals into the confined establishment;  
(b) they have been kept in quarantine in a vector -protected facility in the approved confined establishment for a period of at least 30 days prior to 
the date of dispatch to the Union and have been subjected to a PCR test for infection with bluetongue virus (1 -24) and infection with epizootic 
haemorrhagic disease virus in accordance with  the OIE Terrestrial Manual, with negativ e results, carried out at least 14 days after the introduction into 
the confined establishment;  
(c) they come from a seasonally disease -free area and have been subjected during that disease -free period to a serology test for infection with 
bluetongue viru s (1-24) and infection with epizootic haemorrhagic disease virus  according to the OIE Terrestrial Manual, with negative results, carried Infections with 
epizootic 
haemorrhagic  
Disease  virus   
EN 38  EN out at least 28 days after introduction of the animals into the confined establishment;  
(d) they come from a seasonally free area and have been subjected during that period to a PCR test for infection with bluetongue virus (1 -24) and 
infection with epizootic haemorrhagic disease virus in accordance with the OIE Terrestrial Manual, with negative result s, carried out at least 14 days 
after the introduction of the animals into the approved confined establishment .  
EN 39  EN PART E 
Requirements as regards the absence of vaccination  for certain diseases for the third country  or territory of origin or zone thereof and for the 
ungulates  intended for confined establishments:  
 1. Bovine 
animals  2. Ovine 
animals  3. Caprine 
animals  4. Porcine 
animals  5. Camelid 
animals  6. Cervid 
animals  7. Ungulates 
others than 
those referred to 
in columns  
1,2,3,4,5,6*  
Foot and mouth disease  NVA  NVA  NVA  NVA  NVA  NVA  NVA  
Rift Valley fever virus  NVA**  NVA**  NVA**  NA NVA**  NVA**  NVA**  
Classical swine fever  NA NA NA NVA  NA NA NA 
Brucella  (B. abortus , 
B.melitensis  and B.suis ) NVA**  NVA**  NVA**  NVA**  NVA**  NVA**  NVA**  
Aujeszky's disease virus  NA NA NA NVA  NA NA NA 
 
NVA = the ungulates intended to the Union have not been vaccinated  
NA = not applicable  
* only applicable for listed species in accordance with Regulation (EU) 2018/1882  
** or alternative  guarantees are  provided by the competent authority of the third country or territory according to Part D of this Annex   
EN 40  EN PART F 
Requirements  for the vector -protected structure required in confined establishments in 
third countries  
Where required  in Part D of this Annex,  the vector -protected structure in the confined 
establishments in third countries or territories must comply with the following requirements:  
(a) have appropriate physical barriers at entry and exit points;  
(b) the openings of the vector -protected structure must be vector -screened with mesh of 
appropriate gauge, impregnated regularly with an approved insecticide according to 
the instructions of the manufacturer;  
(c) vector surveillance and control must be carried out within and around the vector -
protected structure;  
(d) measures  must be taken to limit or eliminate breeding sites for vectors in the vicinity 
of the vector -protected structur e;  
(e) standard operating procedures must be in place, including descriptions of back -up 
and alarm systems, for the operation of the vector -protected structure and for the 
transport of the animals from that structure to the place of loading  for dispatch to th e 
Union .  
EN 41  EN ANNEX XIII  
MINIMUM REQUIREMENTS FOR VACCINATION PROGRAM MES AND 
ADDITIONAL SURVEILLANCE CARRIED OUT  IN A THIRD COUNTRY OR 
TERRITORY OR ZONE THEREOF VACCINATING AGAINST HIGHLY  
PATHOGENIC AVIAN INFLUENZA  
1. Minimum requirements for vaccination programmes  carried out in a third 
country or territory  or zone thereof   
Vaccination programmes  against highly pathogenic avian influenza submitted  by a 
third country or territory must include at least the following information:  
(1) Objectives of the vaccination strategy, selected bird population(s) and area . 
(2) Data on the epidemiological evoluti on of the disease , including previous 
outbreaks in po ultry or wild birds . 
(3) Description of the reasons for the decision on the introduction of vaccination . 
(4) Risk assessment based on:  
– Highly pathogenic a vian influenza outbreak s within that third country  or 
territory or zone  thereof ; 
– Highly pathogenic a vian influenza outbreak  in a neighbo uring country ; 
– Other risk factors such as certain areas, type of poultry husbandry or 
categories of poultry or other captive birds . 
(5) Geographical area where vaccination is carried out . 
(6) Number of establishments in vaccination area . 
(7) Number of establishments where vaccination is carried out, if different from 
number in point 6 . 
(8) Species and categories of poultry or captive birds in the geographical area 
where vaccination is carried out . 
(9) Approximate number o f poultry or captive birds in the establishments referred 
to in point 7 . 
(10) Summary of the vaccine characteristics, authorisation and quality control . 
(11) Handling, storage, supply, distribution and sale of avian influenza vaccines on 
the national terri tory. 
(12) Implementation of a Differentiating Infected from Vaccinated Animals ( DIVA ) 
strategy . 
(13) Envisaged duration of vaccination campaign . 
(14) Provisions and restrictions on the movements of vaccinated poultry and poultry 
products derived from vaccinated poultry or vaccinated captive birds . 
(15) Clinical and laboratory tests carried out in the establishments vaccinated or 
located in the vaccination area , such as efficacy and pre -movement testing . 
(16) Means of record keeping .   
EN 42  EN 2. Additional surv eillance in third countries or territories or zones thereof that 
carry out vaccination against highly pathogenic avian influenza   
Where vaccination is carried out in a third country  or territory or zone thereof , all 
establishments where vaccination against avian influenza is carried out must be 
required to undergo laboratory testing and the following information, in addition to 
the information referred to in Annex 2, shall be submitted  to the Commission : 
(1) Number of vaccinated establishments in the area per category  
(2) Number of vaccinated establishments to be sampled per poultry  category  
(3) Use of sentinel birds ( namely, the species and number of sentinel birds used 
epidemiological unit   
(4) Number of samples taken per establishment and/or epidemiological unit  
(5) Data on vaccine efficacy.   
EN 43  EN ANNEX XIV 
ANIMAL HEALTH REQUIREMENTS FOR RATITES, HATCHING EGGS 
THEREOF AND FRESH MEAT OF RATITES ORIGINATING IN A THIRD 
COUNTRY OR TERRITORY OR ZONE THEREOF NOT FREE FROM INFECTION 
WITH NEWCASTLE DISEASE VIRUS  
1. Breeding ratites, productive ratites and ratites intended for slaughter originating in a 
third country or territory or zone thereof not free from infection with Newcastle 
disease virus must : 
(a) have been placed under offici al surveillance for a period of at least 21 days 
prior to the date of dispatch of the consignment for entry into the  Union;  
(b) during the period referred to in point (a), they must have been kept in complete 
isolation away from direct or indirect contact with other birds , in facilities 
approved by the competent authority of the third country or territory of origin 
for this purpose;  
(c) have undergone a virus detection test for infect ion with Newcastle disease 
virus;  
(d) come from flocks in which surveillance for infection with Newcastle disease 
virus was carried out under a statistically based sampling plan which produced 
negative results for a period of at least six months immediatel y prior to the date 
of dispatch of the consignment for entry into the Union.  
2. Day-old chicks of ratites and hatching eggs of ratites originating in a third country or 
territory or zone thereof not free from infection with Newcastle disease virus, must 
come from flocks:  
(a) which were  placed in isolation under official surveillance for a period of at 
least 30 days  prior to the date of laying of the hatching eggs intended for entry 
into the Union or from which the day -old chicks destined for entry into the 
Union are derived;  
(b) which underwent  a virus detection test for infection with Newcastle disease 
virus;  
(c) where surveillance for infection with Newcastle disease virus was carried out 
under a statistically based sampling plan which produced negative re sults for a 
period of at least six months immediately prior to the date of dispatch of the 
consignment for entry to the Union;  
(d) which during the  period of  30 days prior to the date of and during the laying of 
the hatching eggs intended for entry into th e Union or from which the day -old 
chicks destined for entry into the Union are derived, were not in contact with 
poultry which do not fulfil the guarantees under points  (a), (b) and (c).  
3. Fresh meat of ratites originating in a third country or territory or zone thereof not free 
from infection with Newcastle disease virus must : 
(a) be de -boned and skinned;  
(b) come from ratites which were kept for a period of at least three months prior to 
the date of slaughter on establishments:   
EN 44  EN (i) on which there was no outbreak of infection with Newcastle disease virus 
or highly pathogenic avian influenza during the period of  six months  
prior to the date of slaughter ;  
(ii) around which no outbreaks of highly pathogenic avian influenza or 
infection with Newcastle dise ase virus occurred for a period of at least 
three months prior to the date of slaughter, with a distance of 10 
kilometres  from the perimeter of that part of the establishment which 
contains the ratites, including where appropriate the territory of a 
neighb ouring Member State or third country;  
(iii) on which surveillance for infection with Newcastle disease virus was 
carried out under a statistically based sampling plan, which produced 
negative results for a period of at least six months  prior to the date of 
slaughter . 
(c) surveillance  as referred to  in point (b)(iii) must have been carried out:  
(i) by serology, in the case of ratites not vaccinated against infection with 
Newcastle disease virus;  
(ii) by tracheal swabs of ratites, in the  case of ratites vaccinated against 
infection with Newcastle disease virus;  
(d) come from ratites which, if they were vaccinated against infection with 
Newcastle disease virus, they were not vaccinated with vaccines that d id not 
meet the specific criteria set out in Part 1  of Annex 15 in the period of 30 days 
prior to the date of  slaughter.  
4. The virus detection testing provided for in paragraphs 1(c) and 2(b) must have been 
carried out:  
(a) within the period of 7 to 10 days after the date of the entry of the ratites in  
isolation ; 
(b) on cloacal swabs or faeces samples from each bird.  
5. The virus detection testing provided for in paragraphs 1(c) and 2(b) must  have show n 
that no avian paramyxovirus type 1 isolates with an Intracerebral Pathogenicity Index 
(ICPI) of more than 0.4  was found and favourable results must have been available 
from all birds in the consignment before:  
(a) breeding ratites, productive ratites or ratites intended for slaughter have left the 
facilities referred in 1(b) for dispatch to the Union;  
(b) day-old chicks have left the hatchery for dispatch to the Union;  
(c) hatching eggs have been loaded for dispatch to the Union.   
EN 45  EN ANNEX XV 
CRITERIA FOR VACCINES AGAINST INFECTION WITH NEWCASTLE 
DISEASE VIRUS AND REQUIREMENTS FOR CONSIGNMENTS OF POULTRY, 
HATCHING EGGS AND FRESH MEAT OF POULTRY ORIGINATING FROM A 
THIRD COUNTRY OR TERRITORY OR ZONE THEREOF VACCINATING 
AGAINST INFECTION WITH NEWCASTLE DISEASE VIRUS  
1. Criteria for vaccines against infection with Newca stle disease virus  
1.1. General criteria  
(a) Vaccines must comply with the standards set out in the Chapter on Newcastle 
disease in the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 
of the World Organi sation for Animal Health (OIE).  
(b) Vaccines must be registered by the competent authorities of the third country 
or territory of origin concerned before being allowed to be distributed and 
used. For such registration, the competent authorities of the third country or 
territory of origin con cerned must rely on a complete file submitted by the 
applicant containing data on the efficacy and innocuity of the vaccine. In the 
case of imported vaccines the competent authorities of the third country or 
territory of origin may rely on data checked by the competent authorities of the 
country where the vaccine is produced, as far as these checks have been carried 
out in conformity with OIE standards.  
(c) In addition  to the requirements set out in points (a) and (b) , imports or the 
production and distrib ution of the vaccines must be controlled by the 
competent authorities of the third country or territory of origin concerned.  
(d) Before distribution of the vaccines is allowed, each batch of vaccines must be 
tested on innocuity, in particular regarding at tenuation or inactivation and 
absence of undesired contaminating agents, and  on efficacy on behalf of the 
competent authorities  of the third country or territory of origin .  
1.2. Specific criteria  
Live attenuated vaccines against infection with Newcastle disease virus must be 
prepared from a Newcastle disease virus strain for which the master seed has been 
tested and shown to have an intracerebral pathogenicity index (ICPI) of  either:   
(a) less than 0 .4, if not less than 107 EID50 are administered to each bird in the 
ICPI test;  
or  
(b) less than 0, .5, if not  less than 108 EID 50 are administered to each bird in the 
ICPI test.  
2. Animal health requirements for poultry and hatching eggs originating from a 
third country or territory or zone thereof where vaccines used against infection 
with Newcastle disease virus do not meet the specific criteria set out in Part 1  
Poultry and hatching eggs originating from a third country or territory or zone 
thereof where vaccines used against infection with Newcastle di sease virus do not 
meet the specific criteria set out in point 1.2 of Part 1 , must meet the following 
requirements:   
EN 46  EN (a) poultry and the flocks of hatching eggs must not have been vaccinated with 
such vaccines for a period of at least 12 months prior to the date of loading of 
the consignment for dispatch to  the Union;  
(b) the flocks of origin of poultry and hatching eggs  must have undergone a virus 
isolation test for infection with Newcastle  disease virus not earlier than two 
weeks prior to the date of loa ding of the consignment for dispatch to the Union 
or, in the case of hatching eggs, not earlier than two weeks prior to  the date of 
collection of the eggs:  
(i) carried out in an official laboratory;  
(ii) on a random sample of cloacal swabs taken from at least 60 birds in each 
flock;  
(iii) in which no avian paramyxoviruses with an Intracerebral Pathogenicity 
Index of more than 0 .4 have  been found.  
(c) poultry and the flocks of origin of hatching eggs must have been kept in 
isolation under official surveillance on the establishment of origin during the 
two-week period referred to in point (b);  
(d) poultry and the flocks of origin of hatching eggs must n ot have been in contact 
with poultry  not meeting the requirements set out in points (a) and (b):  
(i) in the case of poultry during the period of 60 days prior to  the date of 
loading of the consignment for dispatch to the Union;  
(ii) in the case of hatchin g eggs, during the period of 60 days prior to  the date 
of collection  of the eggs.  
(e) day-old chicks and the hatching eggs from which the day -old chicks are 
derived must not have been in contact in the hatchery or during transport to the 
Union with poultr y or hatching eggs not meeting the requirements set out in 
points (a) to (d).  
3. Animal health requirements for fresh meat of poultry originating from a third 
country or territory or zone thereof where vaccines used against infection with 
Newcastle diseas e virus do not meet the specific criteria set out in Part 1  
Fresh meat of p oultry originating from a third country or territory or zone thereof 
where vaccines used against infection with Newcastle disease virus do not meet the 
specific criteria set out in point 1.2 of Part 1 , must originate from poultry that meet 
the following health requirements:  
(a) the poultry have not been vaccinated with live attenuated vaccines prepared 
from an infection with Newcastle disease virus master seed showing a higher 
patho genicity than lentogenic strains of the virus within the period of 30 days 
prior to the date of slaughter;  
(b) the poultry underwent a virus isolation test for infection with Newcastle 
disease virus, carried out in an official laboratory at the time of sla ughter on a 
random sample of cloacal swabs from at least 60 birds in each flock concerned 
and in which no avian paramyxoviruses with an Intracerebral Pathogenicity 
Index (ICPI) of more than 0,4 were found;   
EN 47  EN (c) the poultry have not been in contact during t he period of 30 days prior to the 
date of slaughter with poultry that  does not fulfil the conditions set out in 
points (a) and (b).  
4. Information to be provided when flocks of poultry and hatching eggs are 
vaccinated against infection with Newcastle disea se virus  
Where flocks of poultry and hatching eggs are vaccinated against infection with 
Newcastle disease virus, the following information shall be provided for the 
consignment:  
(a) identification of the flock;  
(b) age of the birds;  
(c) date of vaccination;  
(d) name and type of virus strain used;  
(e) batch number of vaccine;  
(f) name of vaccine;  
(g) manufacturer of vaccine.   
EN 48  EN ANNEX XVI 
REQUIREMENTS AS REGARDS THE INFORMATION TO BE MENTIONED ON 
THE CONTAINERS OF POULTRY, CAPTIVE BIRDS AND HATCHING EGGS  
1. Breeding poultry and productive poultry shall be transported in containers which 
bear the following indications:  
(a) the name and ISO code of the third country or territory of origin;  
(b) the species of poultry concerned;  
(c) the number of animals;  
(d) the category and type of pro duction for which they are intended;  
(e) the name, address and approval number of the establishment of origin;  
(f) the name of the Member State of destination.  
2. Poultry intended for slaughter shall be transported in containers which bear the 
following indications:  
(a) the name and ISO code of the third country or territory of origin;  
(b) the species of poultry concerned;  
(c) the number of animals;  
(d) the category and type of production for which they are intended;  
(e) the name, address and registration number of the establishment of o rigin;  
(f) the name of the Member State of destination.  
3. Day-old chicks shall be transported in containers which shall bear the following 
indications:  
(a) the name and ISO code of the third country or territory of origin;  
(b) the species of poultry concerned;  
(c) the number of animals;  
(d) the category and type of production for which they are intended;  
(e) the name, address and approval number of the establishment of origin of the 
day-old chicks;  
(f) the approval number of the establishment of origin of the flock of origin;  
(g) the n ame of the Member State of destination.  
4. Captive birds shall be transported in containers which bear the following indications:  
(a) the name and ISO code of the third country or territory of origin;  
(b) the number of animals;  
(c) the name, address and approval number o f the establishment of origin;  
(d) the specific identification number of the container;  
(e) the name of the Member State of destination.   
EN 49  EN 5. Hatching eggs of poultry shall be transported in containers which bear the following 
indications:  
(a) the word "hatching";  
(b) the name  and ISO code of the third country or territory of origin;  
(c) the species of poultry concerned;  
(d) the number of eggs;  
(e) the category and type of production for which they are intended;  
(f) the name, address and approval number of the establishment of origin of the 
eggs; 
(g) the approval number of the establishment of origin of the flock of origin, if 
different from point (f);  
(h) the name of the Member State of destination.  
6. Specified pathogen -free eggs shall be transported in containers which bear the 
following indications:  
(a) the wording "SPF eggs for diagnostic, research or pharmaceutical use only;  
(b) the name and ISO code of the third country or territory of origin;  
(c) the number of eggs;  
(d) the name, address and approval number of the establishment of origin;  
(e) the name of the Member S tate of destination.  
7. Hatching eggs of captive birds shall be transported in containers which bear the 
following indications:  
(a) the name and ISO code of the third country or territory of origin;  
(b) the number of animals;  
(c) the name, address and approval number of the establishment of origin;  
(d) the specific identification number of the container;  
(e) the name of the Member State of destination.   
EN 50  EN ANNEX XVII  
REQUIREMENTS FOR TESTING OF CONSIGNMENTS OF LESS THAN 20 
HEADS OF POULTRY OTHER THAN RATITES AN D LESS THAN 20 HATCHING 
EGGS THEREOF BEFORE THE ENTRY INTO THE UNION  
Consignments of less than 20 heads of poultry other than ratites or less than 20 hatching eggs 
of poultry other than ratites must  have been tested negative for the diseases referred to in  
point ( e) of Article 49 and point ( e)(ii) of Article 111 as follows:   
(a) in the case of breeding poultry, productive poultry and poultry intended for slaughter 
other than ratites, the animals must have been tested negative in serological and/or 
bacteriol ogical tests, within the period of 30 days prior to the date of loading of the 
consignment for dispatch  to the Union ;  
(b) in the case of hatching eggs of poultry other than ratites and day -old chicks other 
than ratites, the flock or origin must have tested negative in serological tests and/or 
bacteriological tests within the period of 90  days prior to the date of loading of the 
consignment  for dispatch to the Union at a level which gives 95 % confidence of 
detecting infection at 5 % prevalence;  
(c) where the animals have been vaccinate d against the infection with any serotype of 
Salmonella  or Mycoplasma , only bacteriological testing must be used, but the 
confirmation method must be capable of differentiating live vaccinal strains from 
field strain s.  
EN 51  EN ANNEX XVIII  
SAMPLING AND TESTING OF POULTRY OTHER THAN RATITES AFTER THE 
ENTRY INTO THE UNION  
1. The official veterinarian shall take samples from breeding poultry other than ratites, 
productive poultry other than ratites and day-old chicks thereof  which have entered 
into the Union from a third country or territory or zone thereof, for virological 
examination as follows:  
(a) Between the seventh and the fifteenth day following the date when they were 
placed on the establishments of destination  in the Union , cloacal swabs must be 
taken at a level which gives a 95% confidence of detecting infection at 5% 
prevalence;  
(b) Testing of samples must be carried out for:  
(i) highly pathogenic avian influenza;  
(ii) infectio n with Newcastle disease virus.  
2. Samples may be pooled, subject to a maximum of five samples from individual birds 
in each pool.   
EN 52  EN ANNEX XIX 
ANIMAL HEALTH REQUIREMENTS FOR GRANTING APPROVAL OF THE 
ESTABLISHMENT OF ORIGIN OF CAPTIVE BIRDS  
1. The animal health requirements in relation to biosecurity measures, as referred to in 
Article 57, shall be the following:  
(a) only animals coming from other approved establishment s are introduced into 
the establishment ; 
(b) were birds are introduced into the  establishment from sources other than 
approved establishments, they may be introduced in to the establishment after 
approval for such an introduction is given by the competent authority of the 
third country or territory, provided that such animals are isol ated for a period of 
at least 30 days from the date they were introduced into the establishment in 
accordance with the instructions given by the competent authority of the third 
country or territory , before being added to the collection  of birds on the 
establishment .  
2. The animal health requirements in relation to the facilities and equipment  on the 
establishment , as referred to in Article 57, shall be the following:  
(a) the establishment  must be clearly demarcated and separated from its 
surroundings;  
(b) the establishment must have adequate means for catching, confining and 
isolating animals and have available adequate approved quarantine facilities 
and approved procedures for animals coming from establishments that have not 
been approved;  
(c) the e stablishment must either have suitable arrangements or on -site facilities 
and equipment for the appropriate disposal of the bodies of animals which die 
of a disease or are euthanised.  
3. The animal health requirements of the establishment in relation to reco rd keeping, as 
referred to in Article 57, shall be the following:  
(a) it must keep up -to-date records indicating:  
(i) the number and identity ( namely, the age, sex, species and individual 
identification number where practical) of the animals of each species 
present in the establishment;  
(ii) the number and identity ( namely, the age, sex, species and individual 
identification number where practical) of animals arriving in the 
establishment or leaving it, together with information on their origin or 
destination , the transport from or to the establishment and the animal 
health status;  
(iii) the results of blood tests or any other diagnostic procedures;  
(iv) cases of disease and, where appropriate, the treatment administered;  
(v) the results of the post -mortem examinations on animals that have died in 
the establishment, including still -born animals;  
(vi) observations made during any isolation or quarantine period.   
EN 53  EN (b) the establishment shall keep the records referred to in point (a) following the 
date of approval, for a period of at least 10 years.  
4. The animal health requirements in relation to personnel  on the establishment , as 
referred to in Article 57, shall be the following:  
(a) the person responsible for the establishment must have a dequate ability and 
knowledge;  
(b) the operator responsible for the establishment  must secure, by contract or other 
legal instrument, the services of a veterinarian approved by and under the 
control of the competent authority of the third country or territory , who:  
(i) shall ensure that appropriate disease surveillance and control measures in 
relation to the disease situation of the third country or territory concerned 
are approved by the competent authority and applied in the 
establishment ; such measures must include  the following :  
– an annual disease surveillance plan including appropriate zoonoses 
control of the animals;  
– clinical, laboratory and post -mortem testing of animals suspected to 
be affected by diseases;  
– vaccination of susceptible animals again st diseases as appropriate, 
in conformity with the Terrestrial Animal Health Code and the 
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 
of the World Organisation for Animal Health (OIE);  
(ii) shall ensure that any suspect deaths or the p resence of any other 
symptoms suggesting that animals have contracted highly pathogenic 
avian influenza, infection with Newcastle disease virus or avian 
chlamydiosis  is notified without delay to the competent authority of the 
third country or territory;  
(iii) shall ensure that animals entering the establishment have been isolated as 
necessary, and in accordance with the requirements of Articles … and the 
instructions, if any, given by the competent authority  of the third country 
or territory ; 
(iv) shall be responsible for the day to day compliance with the animal health 
requirements  laid down in Article .. . 
5. The animal health requirements of the establishment in relation to health status , as 
referred to in Article 57, shall be the following:  
(a) it must be free from highly pathogenic avian influenza, infection with 
Newcastle disease virus and avian chlamydiosis ; in order for the establishment 
to be declared free from those diseases, the competent authority of the third 
country or territory shall assess the records  on the animal health status kept for 
a period of at least three years prior to the date of the application for approval 
and the results of the clinical and laboratory tests carried out on the animals 
therein. However, new establishments shall only be appr oved on the results of 
the clinical and laboratory tests carried out on the animals in such 
establishments;  
(b) it must either have an arrangement with a laboratory  to perform post -mortem 
examinations, or have one or more appropriate premises where such  
EN 54  EN exami nations may be performed by a competent person under the authority of a 
veterinarian  approved for that purpose by the competent authority of the third 
country or territory .  
EN 55  EN ANNEX XX 
EXAMINATION, SAMPLING AND TESTING PROCEDURES OF CAPTIVE BIRDS 
FOR HIGHLY PATHOGENIC AVIAN INFLUENZA AND NEWCASTLE DISEASE  
1. During quarantine either the sentinel birds, or if sentinel birds are not used, the 
captive birds, shall be subjected to the following procedures:  
(a) with the use of sentinel birds:  
(i) blood samples for serological examination must be taken from all 
sentin el birds within a period of not less then 21 days following  the date 
of their entry into the quarantine and within a period of at least three days 
prior to the date of the end of the quarantine;  
(ii) if sentinel birds show positive or inconclusive serolog ical results for the 
samples referred to in point (i) : 
– the imported birds must be subjected to a virological examination;  
– cloacal swabs (or faeces) and tracheal  or oropharyngeal swabs must 
be taken from at least 60 birds or from all birds if the consignmen t 
is less than 60 birds;  
(b) without the use of sentinel birds : 
– imported birds must be examined virologically ( namely, serological 
testing not being appropriate) ; 
– Tracheal  or oropharyngeal or cloacal swabs (or faeces) must be taken 
from at least 60 birds or f rom all birds if the consignment is less than 60 
birds, during the period of the first 7 to 15 days of the quarantine.  
2. In addition to the testing set out in point 1, the following samples shall be taken for 
virological examination:  
(a) cloacal swabs (or faec es) and tracheal  or oropharyngeal swabs, if possible, 
from clinically ill birds or ill sentinel birds;  
(b) from the intestinal contents, brain, trachea, lungs, liver, spleen, kidneys and 
other obviously affected organs as soon as possible following the death from 
either:  
(i) dead sentinel birds and all birds dead on arrival in the quarantine and 
those which die during quarantine;  
or  
(ii) in the case of high mortality in small birds of large consignments , from at 
least 10 % of the dead birds.  
3. For virological examination , pooling of samples up to a maximum of five samples of 
individual birds in one pool shall be allowed.  
Faecal material must be pooled separately from other organ and tissue samples.   
EN 56  EN ANNEX XXI 
SPECIFIC REQUIREMENTS AS REGARDS DOGS, CATS AND FERRETS 
INTENDED FOR ENTRY INTO THE UNION  
1. ANTIBODY RABIES TITRATION TEST REQUIREMENTS:  
(a) Must be carried out on a sample collected by a veterinarian authorised by the 
competent authority during the period c ommencing at least 30 days after the 
date of vaccination and ending 3 months before the date of issue of the 
certificate.  
(b) must measure a titre of neutralising antibody to rabies virus equal to or greater 
than 0,5 IU/ml ; 
(c) must be certified by an official re port from the official laboratory on the result 
and a copy of this report must be attached to the animal health certificate 
accompanying the animals  to the Union ; 
(d) does not have to be renewed on an animal, which following the antibody rabies 
titration test with satisfactory results, has been revaccinated against rabies 
within the period of validity of the previous vaccination  referred to in point (a) . 
2. TREATMENT AGAINST INFESTATION WITH ECHINOCCOCUS 
MULTILOCULARIS  
Prior to the entry into the Union, dogs shall be treated against infestation with 
Echinococcus multilocularis , as follows:  
(a) the treatment must consist of an approved medicinal product which contains 
the appropriate dose of praziquantel or pharmacologically active substances, 
which alone or in combination, have proven to reduce the burden of mature and 
immature intestinal forms of Echinococcus multilocularis  in the host species 
concerned;  
(b) the treatment must be administered by a veterinarian within a period 
commencing  not more than 120 hours and ending not less than 24 hours before 
the time of arrival in the Union;  
(c) the following details o f the treatment must be certified by the administering 
veterinarian in the document referred to in Article 76(1)(a)(iv) : 
(i) transponder or tattoo alphanumeric code of the dog, cat or ferret ; 
(ii) name of the product and manufacturer of the treatment against infestation 
with Echinococcus multilocularis ; 
(iii) date and time of treatment ; 
(iii) name, stamp and signature of the adm inistering veterinarian.   
EN 57  EN ANNEX XXII  
REQUIREMENTS AS REGARDS THE RESIDENCY PERIODS OF HATCHING 
EGGS BEFORE THE ENTRY INTO THE UNION  
Category of 
hatching eggs  Minimum 
residency 
period 
applies to  Minimum 
residency period in 
the third country 
or territory of 
origin or zone 
thereof, as referred 
in Article 98(a) Minimum residency 
period in the 
establishment of 
origin, as referred to 
in Article 98(b) Minimum period 
without contact 
with poultry or 
hatch ing eggs of 
lower health status, 
captive birds or 
wild birds  as 
referred to in 
Article 98(c) 
Hatching 
eggs of 
poultry  Flock of 
origin  3 months  6 weeks  6 weeks  
Consignments 
of Less than 
20 hatching 
eggs of 
poultry other 
than ratites  Flock of 
origin  3 months   
3 weeks  
 3 week   
EN 58  EN ANNEX  XXIII  
REQUIREMENTS AS REGARDS THE RESIDENCY PERIOD BEFORE 
SLAUGHTER OR KILLING OF THE KEPT UNGULATES OF ORIGIN OF THE 
FRESH MEAT   
1. The period during  which the ungulates must have remain ed in the third country or 
territory of origin or zone thereof before  the date of  slaughter  or killing , as referred to 
in Article 131 (2)(a) , shall be  either : 
(a) at least three months  prior that date ; or 
(b) less than three months  prior to that date , if the ungulate s are less than three 
months of age.  
2. The period for which the kept ungulates must have remain ed in their establishment of 
origin without having come into contact with ungulates of a lower health status, as 
referred to in Article 131 (2)(b) and (c) , shall be  a period of at least 40 days prior to 
the date of slaughter or killing  where  such animals : 
(a) originate from a third country, territory or zone thereof which applies  one or 
more of  the specific conditions set out in Part B of Annex 24;  
(b) are covered by deroga tion provided for in Article 132 .  
EN 59  EN ANNEX  XXIV  
DISEASE FREEDOM IN THE THIRD COUNTRY OR TERRITORY OF ORIGIN OF THE PRODUCTS OF ANIMAL ORIGIN  
Part A  
Minimum periods ( in months) of disease freedom of the third country or territory of orig in or zone thereof in accordance with Article 131 (1). 
 
1. Bovine 
animals  2. Ovine 
animals  3. Caprine 
animals  4. Porcine 
animals  5. Camelid 
animals  6. Cervid 
animals  7. Ungulates  other 
than those referred 
to in columns  
1,2,3,4,5,6*  
Foot and mouth disease  12 m**  12 m**  12 m**  12 m**  12 m**  12 m**  12 m**  
Infection with rinderpest virus  12 m  12 m  12 m  12 m  12 m  12 m  12 m  
Rift Valley fever virus  12 m  12 m  12 m  12 m  12 m  12 m  12 m  
Peste des petits ruminants  12 m  12 m  12 m  12 m  12 m  12 m  12 m  
Sheep pox and goat pox  12 m  12 m  12 m  12 m  12 m  12 m  12 m  
African swine fever  NA NA NA 12 m  NA NA NA 
Classical swine fever  NA NA NA 12 m**  NA NA NA 
* only applicable to listed species in accordance with Annex  to Regulation (EU) 1882/2018  
** this period may be reduced  where specific conditions , in accordance with Part B, are provided  by the competent authority of the third country or territory   
EN 60  EN Part B  
Specific conditions to be provided by the competent authorit y where the third country or territory or zone thereof has been free of the disease  for a period of less than 
12 months as provided for in the derogation laid down in Article 131 (2): 
Foot and mouth disease  
Supplementary information to guarantee the determination of a date from which the third country or territory or zone thereof 
shall be considered to be free from the disease  
Classical swine fever   
EN 61  EN ANNEX XXV  
VACCINATION IN THE THIRD COUNTRY OR TERRITORY OF ORIGIN OR ZONE THEREOF AND IN THE ANIMALS OF 
ORIGIN AND OF THE PRODUCTS OF ANIMAL ORIGIN  
Part A  
Animal health Requirements as regards the absence of vaccination in the third country  or territory of origin or zone thereof and for the 
establishment of origin of the ungulates  from which the fresh meat is obtained:  
 1. Bovine 
animals  2. Ovine 
animals  3. Caprine 
animals  4. Porcine 
animals  5. Camelid 
animals  6. Cervid 
animals  7. Ungulates 
other than those 
referred to in 
columns 
1,2,3,4,5,6*  
Foot and mouth disease  NV/NVE**  NV/NVE**  NV/NVE**  NV/NVE  NV/NVE**  NV/NVE**  NV/NVE**  
African swine fever  NA NA NA NV/NVE  NA NA NA 
Classical swine fever  NA NA NA NV/NVE  NA NA NA 
NV = for a period of at least 12 m onths prior to the date of dispatch to the Union : No vaccination has been carried out in the third country or territory or zone 
thereof and there have been no entries of vaccinated animals in the third country territory or zone  
NVE= no vaccinated animals in the establishment of origin of the ungulates from which the fresh meat is obtained  
NA = not applicable  
* only applicable for listed species in accordance with Annex to  Regulation (EU) 2018/1882   
** or specific conditions , in a ccordance with Part B, are provided by the competent authority of the third country or territory   
EN 62  EN Part B  
Specific conditions to be provided  by the competent authorities where vaccination 
against foot and mouth disease has been carried out in the third country or territory or 
zone thereof for a period of less than 12 months as referred to in Article 131 (4). 
1. FROM A THIRD COUNTRY , TERRITORY OR Z ONE THEREOF WHICH IS  FREE FROM 
FOOT AND MOUTH DISEA SE AND WHERE VACCINA TION FOR FOOT AND MO UTH 
DISEASE STRAINS A, O OR C IS PRACTISED   
The competent authorities of the third country or territory of origin has  provided 
supplementary information to guarantee  the absence of foot and mouth disease virus 
in fresh meat and compliance with the following requirements:  
(a) a vaccination programme against foot and mouth disease is carried out and 
controlled by the competent authorit y of the third country or territor y of origin;  
(b) either:  
(i) in case of bovine, ovine and caprine animals, which originate from 
establishments, in and around which, in an area with a 25 k ilometres  
radius, there has been no reported case or outbreak of foot and mouth 
disease or rinderpest  during the period of 60 days  prior  to the date of 
dispatch to the Union ; 
(ii) in case of kept ungulates other than bovine, ovine and caprine, porcine 
and equine animals, originate from establishments in and around which 
in an area of 50 k ilometres  radius,  there has been no reported case or 
outbreak of foot and mouth disease or rinderpest, during the period of 90 
days prior  to the date of dispatch to the Union ; 
(c) the meat is fresh meat other than offal, is de -boned meat and obtained from 
carcasses:  
(i) in which the main accessible lymphatic glands have been removed;  
(ii) which have been submitted to maturation at a temperature above +2°C 
for at least 24 hours before the bones were removed;  
(iii) in which the pH value of the meat was below 6,0 when tested 
electronically in the middle of the longissimus -dorsi  muscle after 
maturation and before de -boning.  
2. FROM A THIRD COUNTRY , TERRITORY OR ZONE TH EREOF WHICH IS FREE FROM 
FOOT AND MOUTH DISEA SE AND WHERE VACCINA TION FOR FOOT -AND-MOUTH 
DISEASE STRAI NS A, O OR C IS PRACTISED  
In addition to the requirements set out in point 1 the competent authority of the third 
country or territory has provided additional guarantees for conditions which are 
specific for the third country, territory or zone thereof and  which support the absence 
of foot and mouth disease virus in the fresh meat from the zone.   
EN 63  EN 3. FOOT AND MOUTH DISEAS E FREE ZONES WHERE V ACCINATION IS NOT PR ACTISED  
3.1. Foot and mouth disease strains SAT or ASIA 1  
The competent authorities of a third country or t erritory of origin shall provide the 
necessary supplementary information to guarantee the absence of the foot and mouth 
disease virus in the fresh meat and compliance with the following animal health 
requirements; where the fresh meat originates from a foo t and mouth freedom  zone 
where vaccination is not practised , but which is in a third country or territory in 
which vaccination for FMD strains SAT or ASIA 1 is practiced in other zones or 
where those strains are endemic in part(s) of the third country or t erritory or in the 
neighbouring Member State or third countries:  
(a) the animals originate from establishments in and around which, in an area with 
a 10 k ilometres  radius, there has been no case  or outbreak of foot and mouth 
disease [or rinderpest] during the period of 12 months  prior to the date of… ; 
(b) the meat is not authorised  for export to the Union until 21 days have elapsed 
following the date of slaughter;  
(c) the meat is fresh meat other than offal,  is de-boned meat and obtained from 
carcasses:  
(i) in which the main accessible lymphatic glands have been removed;  
(ii) which have been submitted to maturation at a temperature above +2°C 
for a period of at least 24 hours before the bones were removed.  
3.2. Foot and mouth disease strains A, O or C  
The competent authorities of the third country or territory of origin shall provide the 
following supplementary information, where the fresh meat originates in a foot and 
mouth disease -free zone where vaccination against foot and mouth disease is not 
practised , but which is in a third country or territory in which vaccination against 
foot and mouth disease strains A, O or C is practised, and the competent authorities 
of the third country or territory have provided additional guarantees on conditions 
which are s pecific for the third country or territory or zone and which support the 
absence of foot and mouth disease virus in the fresh meat from the zone:  
(a) the surveillance programme for foot -and-mouth disease applicable for the free 
zone, demonstrating the abs ence of foot and mouth disease is carried out and 
controlled by the competent authorities of the third country or territory of 
origin ;  
(b) guarantees on the application of the animal health requirements set out in 
points (b) and (c) of P art 1;   
EN 64  EN ANNEX XXVI  
RISK MITIGATING TREATMENTS FOR MEAT PRODUCTS  
1. RISK MITIGATING TREAT MENTS FOR MEAT PRODU CTS LISTED IN DESCEN DING 
ORDER OF SEVERITY :  
B = Treatment in a hermetically sealed container to a Fo value of three or more.  
C = A minimum temperature of 80°C , which must be reached throughout the meat product 
during its processing.  
D = A minimum temperature of 70°C , which must be reached throughout the meat or stomachs, bladders and 
intestines during the processing of meat products and treated stomachs, bladders and intestines, or for raw ham, 
a treatment consisting of natural fermentation and maturation of not less than nine months and resulting in the 
following characteristics:  
— Aw value of not more than 0,93 ; 
— pH value of not more than 6,0.  
D1 = Thorough the cooking of meat, previously deboned and defatted, subjected to heating so that an internal 
temperature of 70°C or greater is maintained for a minimum period of 30 minutes.  
E = In the case of ‘biltong’ -type products, a treatment to achieve:  
— Aw value of not more than 0,93 ; 
— pH value of not more than 6,0.  
F = A heat treatment ensuring that a center temperature of at least 65°C is reached for a period of time as necessary 
to achieve a pasteurization value (Pv) equal to or above 40.  
2. RISK MITIGATING TREATMENTS FOR CASIN GS: 
Casing 1 = Salting with sodium chloride (NaCl), either dry or as saturated brine 
(aw < 0,80), for a continuous period of 30 days or longer, at a temperature of 20°C or 
above.  
Casing 2 = Salting with phosphate supplemented salt conta ining 86,5 % NaCl, 10 ,7 % 
Na2HPO4 and 2,8% Na3PO4 (weight/weight/weight), either dry or as saturated brine (aw  < 
0.80), for a continuous period of 30 days or longer, at a temperature of 20°C or above.  
Casing 3  = Salting with NaCl for 30 days  
Casing 4  = Ble aching  
Casing 5  = Drying after scraping.   
EN 65  EN ANNEX XXVII  
RISK MITIGATING TREATMENTS FOR MILK AND  DAIRY PRODUCTS  
 A B 
Species of origin of  the milk and the 
dairy products  Bos Taurus, Ovis aries, 
Capra hircus, Bubalus 
bubalis and Camelus  
dromedarius  Other than  Bos Taurus, 
Ovis aries, Capra 
hircus, Bubalus bubalis 
and Camelus 
dromedarius  
Animal health status of the third 
country  1. Third countries not 
officially free of  
foot and mouth 
(FMD ) for the 
preceding 12 
months  
2. Third countries 
where vaccination 
against FMD is 
practiced  Any 
Sterilization process, to achieve an F o 
value equal to or greater than 3  Yes Yes 
Ultra -high temperature (UHT) treatment 
at not less than 135°C in combination 
with a suitable holding time  Yes Yes 
High temperature short time 
pasteurization treatment (HTST) at 72°C 
for 15 seconds applied twice to milk with 
a pH equal to or greater than 7 ,0 
achieving, where applicable, a negative 
reaction to a alkaline phosphatase test, 
applied immediately after the heat 
treatment  Yes No 
HTST treatment of milk with a pH below 
7,0 Yes No 
HTST treatment combined with another 
physical treatment by either:  
(i) lowering the pH below 6 for one 
hour, or  
(ii) additional heating equal to or 
greater than 72 °C, combined with 
desiccation  Yes No 
No: treatment not permitted  
Yes: required treatment   
EN 66  EN ANNEX  XXVIII  
RISK MITIGATION  TREATMENTS FOR  EGG PRODUCTS  
1. TREATMENTS OF EGG PRO DUCTS FOR THE INACTIVATION OF HIGHLY PATHOGENIC 
AVIAN INFLUENZA VIRU SES 
(c) Liquid egg white, either with 55,6oC for 870 seconds or with 56,7oC for 232 
seconds.  
(d) 10% salted yolk, with 62,2oC for 138 seconds.  
(e) Dried egg white, either with 67oC for 20 hours or with 54,4oC for 513 hours.  
(f) Whole eggs, either at least with 60oC for 188 se conds, or completely cooked.  
(g) Whole egg blends, either at least with 60oC for 188 seconds, at least with 
61,1oC for 94 seconds, or completely cooked.  
2. TREATMENTS OF EGG PRO DUCTS  FOR THE INACTIVATION  OF INFECTION WITH 
NEWCASTLE DISEASE VIR US 
(a) Liquid egg white,  either with 55oC for 2278 seconds, with 57oC for 986 
seconds, or with 59oC for 301 seconds.  
(b) 10% salted yolk, with 55oC for 176 seconds.  
(c) Dried egg white, with 57oC for 50 ,4 hours.  
(d) Whole eggs, either at least with 55oC for 2  521 seconds, with 57oC for 1  596 
seconds, with 59oC for 674 seconds, or completely cooked.   
EN 67  EN ANNEX XXIX  
LIST OF SPECIES SUSCEPTIBLE TO DISEASES FOR WHICH MEMBER STATES HAVE NATIONAL MEASURES IN 
ACCORDANCE WITH ARTICLE 226 of REGULATION (EU) 2016/429  
Disease  Susceptible species  
Spring viraemia of carp (SVC)  Bighead carp ( Aristichthys nobilis ), goldfish ( Carassius auratus ), crucian carp ( Carassius 
carassius ), grass carp ( Ctenopharyngodon idellus ), common carp and koi carp ( Cyprinus carpio ), 
silver carp ( Hypophthalmichthys molitrix ), sheatfish ( Silurus glanis ), and tench ( Tinca tinca ), Orfe 
(Leuciscus idus ) 
Bacterial kidney disease (BKD)  Family: Salmonidae  
Infectious pancreatic necrosis (IPN)  Rainbow trout ( Oncorhynchus mykiss ), brook trout ( Salvelinus f ontinalis ), brown trout ( Salmo 
trutta ), Atlantic salmon ( Salmo salar ) and ( Oncorhynchus spp. ), whitefish ( Coregonus lavaretus ) 
Infection with Salmonid alphavirus (SAV)  Atlantic salmon ( Salmo salar ), rainbow trout ( Oncorhynchus mykiss ), brown trout ( Salmo trutta ) 
Infections with Gyrodactylus salaris (GS)  Atlantic salmon ( Salmo salar ), rainbow trout ( Oncorhynchus mykiss ), Arctic char ( Salvelinus 
alpinus ), North American brook trout ( Salvelinus fontinalis ), grayling ( Thymallus thymallus ), 
North American lake  trout ( Salvelinus namaycush ) and brown trout ( Salmo trutta ) 
 
Any species which have been in contact with a susceptible species are also considered susceptible  
Ostreid herpervirus 1 µvar (OsHV -1 µVar)  Pacific oyster ( Crassostrea gigas )  
EN 68  EN ANNEX XXX  
CONDITIONS UNDER WHICH SPECIES LISTED IN COLUMN 4 OF COMMISSION IMPLEMENTING REGULATION (EU) 2018/1882 
ARE  REGARDED AS VECTORS  
List of diseases  Vectors  Conditions under which species of aquatic 
animals listed in column 4 of the Annex of 
Commission Implementing Regulation (EU) 
2018/1882 are regarded as vectors  
Epizootic 
haematopoietic 
necrosis (EHN)  
As listed in the fourth 
column of the Annex 
of Commission 
Implementing 
Regulation (EU) 
2018/1882   Regarded as vectors of EHN under all 
conditions.  
Viral haemorrhagic 
septicaemia (VHS)  Regarded as vectors of VHS when in contact 
with species listed in column 3 of the Annex of 
Commission Implementing Regulation (EU) 
2018/1882 through co -habitation or through 
water supply.  
Infectious 
haematopoietic 
necrosis (IHN)  Regarded as vectors of I HN when in contact 
with species listed in column 3 of the Annex of 
Commission Implementing Regulation (EU) 
2018/1882 through co -habitation or through 
water supply.  
Infection with highly 
polymorphic region 
(HPR) deleted 
infectious salmon 
anaemia virus (HP R-
deleted ISAV)  No vector species listed for HPR -deleted 
ISAV.   
EN 69  EN List of diseases  Vectors  Conditions under which species of aquatic 
animals listed in column 4 of the Annex of 
Commission Implementing Regulation (EU) 
2018/1882 are regarded as vectors  
Infection with 
Mikrocytos mackini  No vector species listed for Mikrocytos 
mackini.  
Infection with 
Perkinsus marinus  Regarded as vectors of Perkinsus marinus 
when in contact with species listed in column 3 
of the Annex of Commission Implementing 
Regulation (EU) 2018/1882 through co -
habitation or through water supply.  
Infection with 
Bonamia ostreae  Regarded as vectors of Bonamia ostreae when 
in contact with s pecies listed in column 3 of the 
Annex of Commission Implementing 
Regulation (EU) 2018/1882 through co -
habitation or through water supply.  
Infection with 
Bonamia exitiosa  Regarded as vectors of Bonamia exitiosa when 
in contact with species listed in column 3 of the 
Annex of Commission Implementing 
Regulation (EU) 2018/1882 through co -
habitation or through water supply.  
Infection with 
Marteilia refringens  Regarded as vectors of Marteilia refringens  
when in cont act with species listed in column 3 
of the Annex of Commission Implementing 
Regulation (EU) 2018/1882 through co -
habitation or through water supply.   
EN 70  EN List of diseases  Vectors  Conditions under which species of aquatic 
animals listed in column 4 of the Annex of 
Commission Implementing Regulation (EU) 
2018/1882 are regarded as vectors  
Infection with Taura 
syndrome virus  Regarded as vectors of Taura syndrome virus 
when in contact with spe cies listed in column 3 
of the Annex of Commission Implementing 
Regulation (EU) 2018/1882 through co -
habitation or through water supply.  
Infection with yellow 
head virus  Regarded as vectors of Taura syndrome virus 
when in contact with species listed in column 3 
of the Annex of Commission Implementing 
Regulation (EU) 2018/1882 through co -
habitation or through water supply.  
Infection with white 
spot syndrome virus  Regarded as vectors of Taura syndrome virus 
when in contact with species listed in column 3 
of the Annex of Commission Implementing 
Regulation (EU) 2018/1882 through co -
habitation or through water supply.